<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Synephrine</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Synephrine">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Synephrine</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Synephrine</b>, or, more specifically, <b><i>p</i>-synephrine</b>, is an alkaloid, occurring naturally in some plants and animals, and also in approved drugs products as its <i>m</i>-substituted analog known as neo-synephrine.<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> <i>p</i>-Synephrine (or formerly <b>Sympatol</b> and <b>oxedrine</b> [BAN]) and <i>m</i>-synephrine are known for their longer acting adrenergic effects compared to norepinephrine. This substance is present at very low concentrations in common foodstuffs such as orange juice and other orange (<i>Citrus</i> species) products, both of the "sweet" and "bitter" variety. The preparations used in traditional Chinese medicine (TCM), also known as Zhi Shi, are the immature and dried whole oranges from <i>Citrus aurantium</i> (Fructus Aurantii Immaturus). Extracts of the same material or purified synephrine are also marketed in the US, sometimes in combination with <a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">caffeine</a>, as a weight-loss-promoting dietary supplement for oral consumption. While the traditional preparations have been in use for millennia as a component of TCM-formulas, synephrine itself is not an approved OTC drug. As a pharmaceutical, <i>m</i>-synephrine (<a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">phenylephrine</a>) is still used as a sympathomimetic (i.e. for its hypertensive and vasoconstrictor properties), mostly by injection for the treatment of emergencies such as shock, and rarely orally for the treatment of bronchial problems associated with asthma and hay-fever.<span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 1;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 1]</span></a></span></p>


<span>
</span><table class="infobox bordered" style="border-collapse:collapse; width:22em; text-align:left; ;">
<caption style="text-align:center;">Synephrine</caption>
<tbody><tr> 
<td colspan="2" style="text-align:center; padding:2px;"><figure-inline><img src="../I/m/Synephrine.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Synephrine.svg.png" data-file-width="512" data-file-height="283" data-file-type="drawing" height="122" width="220"></figure-inline></td></tr>
<tr>
<td colspan="2" style="text-align:center; padding:2px;"><figure-inline><img src="../I/m/Synephrine_Ball_and_Stick.png" tppabs="https://ptable.com/wiki/compounds/I/m/Synephrine_Ball_and_Stick.png" data-file-width="3157" data-file-height="2000" data-file-type="bitmap" height="139" width="220"></figure-inline></td></tr>
<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Names</th></tr>

<tr>

<td colspan="2" style="text-align:left;">IUPAC name
<div style="max-width:22em; word-wrap:break-word; padding-left:1.7em;">4-[1-hydroxy-2-(methylamino)ethyl]phenol</div></td></tr>

<tr>


<td colspan="2" style="text-align:left;">Other names
<div style="max-width:22em; word-wrap:break-word; padding-left:1.7em;"><i>p</i>-synephrine</div></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Identifiers</th></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">CAS Number</div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=94-07-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=94-07-5'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=94-07-5" class="external text external">94-07-5</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>
<td><div style="padding:0.1em 0;line-height:1.2em;">3D model (JSmol)</div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=OC%28c1ccc%28O%29cc1%29CNC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=OC%28c1ccc%28O%29cc1%29CNC'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=OC%28c1ccc%28O%29cc1%29CNC" class="external text external">Interactive image</a></span></li></ul></div></td></tr>

<tr>



<td>ChEBI</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=29081  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=29081'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=29081" class="external text external">CHEBI:29081</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>
<td>ChEMBL</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL33720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL33720'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL33720" class="external text external">ChEMBL33720</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>
<td>ChemSpider</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.6904.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.6904.html'" tppabs="http://www.chemspider.com/Chemical-Structure.6904.html" class="external text external">6904</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>

<td><span>ECHA InfoCard</span></td>
<td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.002.092  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.002.092'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.002.092" class="external text external">100.002.092</a></td></tr>
<tr>




<td>KEGG</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D07148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D07148'" tppabs="https://www.kegg.jp/entry/D07148" class="external text external">D07148</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">PubChem <abbr>CID</abbr></div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/7172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/7172'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/7172" class="external text external">7172</a></span></li></ul></div></td></tr>

<tr>

<td>UNII</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=PEG5DP7434  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=PEG5DP7434'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=PEG5DP7434" class="external text external">PEG5DP7434</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID0030588  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID0030588'" tppabs="https://comptox.epa.gov/dashboard/DTXSID0030588" class="external text external">DTXSID0030588</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr>

<tr>
<td colspan="2"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left; text-align:left; font-weight:normal; background:transparent;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.5em; text-align:left;"><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">InChI=1S/C9H13NO2/c1-10-6-9(12)7-2-4-8(11)5-3-7/h2-5,9-12H,6H2,1H3<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">Key:<span>&nbsp;</span>YRCWQPVGYLYSOX-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></div></li><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.5em; text-align:left;"><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">InChI=1/C9H13NO2/c1-10-6-9(12)7-2-4-8(11)5-3-7/h2-5,9-12H,6H2,1H3</div><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">Key:<span>&nbsp;</span>YRCWQPVGYLYSOX-UHFFFAOYAW</div></div></li></ul>
</div></td></tr>
<tr>
<td colspan="2"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left; text-align:left; font-weight:normal; background:transparent;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.6em; word-wrap:break-word; text-indent:-1.5em; text-align:left; font-size:11px; line-height:120%;">OC(c1ccc(O)cc1)CNC</div></li></ul>
</div></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Properties</th></tr>

<tr>
<td><div style="padding:0.1em 0;line-height:1.2em;">Chemical formula</div></td>

<td>C<sub>9</sub>H<sub>13</sub>NO<sub>2</sub><span> </span></td></tr>

<tr>
<td>Molar mass</td>

<td>167.21 g/mol<span> </span> <span> </span></td></tr>

<tr>
<td>Appearance</td>
<td>colorless solid</td></tr>
<tr>


<td>Melting point</td>
<td><span> </span>162 to 164<span>&nbsp;</span>°C (324 to 327<span>&nbsp;</span>°F; 435 to 437<span>&nbsp;</span>K)<span> </span>(R-(−)-enantiomer); 184 to 185 °C (racemate)</td></tr>

<tr>



<td><div style="padding:0.1em 0;line-height:1.2em;">Solubility in water</div></td>
<td>soluble</td></tr>
<tr>



<th colspan="2" style="background: #f8eaba; text-align: center;">Pharmacology</th></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">ATC code</div></td>
<td>C01CA08<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C01CA08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C01CA08'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C01CA08" class="external text external">WHO</a></span>)<span> </span>S01GA06<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=S01GA06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=S01GA06'" tppabs="https://www.whocc.no/atc_ddd_index/?code=S01GA06" class="external text external">WHO</a></span>), QS01FB90<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atcvet/atcvet_index/?code=QS01FB90  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atcvet/atcvet_index/?code=QS01FB90'" tppabs="https://www.whocc.no/atcvet/atcvet_index/?code=QS01FB90" class="external text external">WHO</a></span>)</td></tr>
<tr>




<td colspan="2" style="text-align:left; background:#f8eaba;"><div style="margin:0 auto; text-align:left;"><div style="padding:0.1em 0;line-height:1.2em;">Except where otherwise noted, data are given for materials in their standard state (at 25<span>&nbsp;</span>°C [77<span>&nbsp;</span>°F], 100<span>&nbsp;</span>kPa).</div></div></td></tr>

<tr style="background:#f8eaba; border-top:2px solid transparent;"></tr>


<tr style="background:#f8eaba; border-top:2px solid transparent;">
<td colspan="2" style="text-align:center;">Infobox<span>&nbsp;</span>references</td></tr>

<tr style="background:#f8eaba;">
<td style="width:40%; max-height:1px; border-top:2px solid transparent; border-right:1px solid transparent;"></td>
<td style="width:60%; max-height:1px; border-top:2px solid transparent; border-left:1px solid transparent;"></td></tr>


</tbody></table>

<p>It is important to distinguish between studies concerning synephrine as a single chemical entity (synephrine can exist in the form of either of two stereoisomers, d- and l-synephrine, which are chemically and pharmacologically distinct), and synephrine which is mixed with other drugs and/or botanical extracts in a "Supplement", as well as synephrine which is present as only one chemical component in a naturally-occurring mixture of phytochemicals such as the rind or fruit of a bitter orange. Mixtures containing synephrine as only one of their chemical components (regardless of whether these are of synthetic or natural origin) should not be assumed to produce exactly the same biological effects as synephrine alone.<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>In physical appearance, synephrine is a colorless, crystalline solid and is water-soluble. Its molecular structure is based on a <a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">phenethylamine</a> skeleton, and is related to those of many other drugs, and to the major neurotransmitters <a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">epinephrine</a> and norepinephrine.</p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Natural_occurrences">Natural occurrences</h2></summary>
    
<p>Synephrine, although already known as a synthetic organic compound, was first isolated as a natural product from the leaves of various <i>Citrus</i> trees, and its presence noted in different <i>Citrus</i> juices, by Stewart and co-workers in the early 1960s.<span class="mw-ref" id="cite_ref-Stew_4-0"><a href="#cite_note-Stew-4" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Stew2_5-0"><a href="#cite_note-Stew2-5" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> A survey of the distribution of synephrine amongst the higher plants was published in 1970 by Wheaton and Stewart.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It has subsequently been detected in <i>Evodia</i><span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> and <i>Zanthoxylum</i> species,<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> all plants of the family Rutaceae.</p>

<p>Trace levels (0.003%) of synephrine have also been detected in the dried leaves of <i>Pogostemon cablin</i> (patchouli, Lamiaceae).<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It is also found in certain cactus species of the genera <i>Coryphantha</i> and <i>Dolichothele</i>.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>

<p>However, this compound is found predominantly in a number of <i>Citrus</i> species, including "bitter" orange varieties.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="In_Citrus">In <i>Citrus</i></h3></summary>
    
<p>Extracts of unripe fruit from Asian cultivars of <i>Citrus aurantium</i> (commonly known as "bitter" orange), collected in China, were reported to contain synephrine levels of about 0.1–0.3%, or ~1–3<span>&nbsp;</span>mg/g;<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Analysis of dried fruit of <i>C. aurantium</i> grown in Italy showed a concentration of synephrine of ~1<span>&nbsp;</span>mg/g, with peel containing over three times more than the pulp.<span class="mw-ref" id="cite_ref-Pellat_12-0"><a href="#cite_note-Pellat-12" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Sweet oranges of the Tarocco, Naveline and Navel varieties, bought on the Italian market, were found to contain ~13–34 μg/g (corresponding to 13–34<span>&nbsp;</span>mg/kg) synephrine (with roughly equal concentrations in juice and separated pulp); from these results, it was calculated that eating one "average" Tarocco orange would result in the consumption of ~6<span>&nbsp;</span>mg of synephrine.<span class="mw-ref" id="cite_ref-Mat_13-0"><a href="#cite_note-Mat-13" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>An analysis of 32 different orange "jams", originating mostly in the US and UK, but including samples from France, Italy, Spain, or Lebanon, showed synephrine levels ranging from 0.05<span>&nbsp;</span>mg/g–0.0009<span>&nbsp;</span>mg/g<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 2;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 2]</span></a></span> in those jams made from bitter oranges, and levels of 0.05<span>&nbsp;</span>mg/g–0.006<span>&nbsp;</span>mg/g<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 3;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 3]</span></a></span> of synephrine in jams made from sweet oranges.<span class="mw-ref" id="cite_ref-Av_16-0"><a href="#cite_note-Av-16" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>Synephrine has been found in marmalade made from <i>Citrus unshiu</i> (Satsuma mandarin)<span class="mw-ref" id="cite_ref-XRef_17-0"><a href="#cite_note-XRef-17" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> obtained in Japan, at a concentration of ~0.12<span>&nbsp;</span>mg/g (or about 2.4<span>&nbsp;</span>mg/20g serving).<span class="mw-ref" id="cite_ref-Kusu_18-0"><a href="#cite_note-Kusu-18" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Most of the orange marmalades made in the US are produced using "sweet" oranges (<i>C. sinensis</i>), whereas "bitter" or Seville oranges (<i>C. aurantium</i>) are used for making the more traditional, bitterer marmalades in the United Kingdom.<span class="mw-ref" id="cite_ref-Blum_19-0"><a href="#cite_note-Blum-19" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>A sample of commercial Japanese <i>C. unshiu</i> juice was found to contain ~0.36<span>&nbsp;</span>mg/g synephrine (or roughly 360<span>&nbsp;</span>mg/L),<span class="mw-ref" id="cite_ref-Kusu_18-1"><a href="#cite_note-Kusu-18" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> while in juice products obtained from a Satsuma mandarin variety grown in California, levels of synephrine ranged from 55 to 160<span>&nbsp;</span>mg/L .<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>Juices from "sweet" oranges purchased in Brazilian markets were found to contain ~10–22<span>&nbsp;</span>mg/L synephrine; commercial orange soft drinks obtained on the Brazilian market had an average synephrine content of ~1<span>&nbsp;</span>mg/L.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Commercial Italian orange juices contained ~13–32<span>&nbsp;</span>mg/L of synephrine<span class="mw-ref" id="cite_ref-Mat_13-1"><a href="#cite_note-Mat-13" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>In a survey of over 50 citrus fruit juices, either commercially-prepared or hand-squeezed from fresh fruit, obtained on the US market, Avula and co-workers found synephrine levels ranging from ~4–60<span>&nbsp;</span>mg/L;<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 4;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 4]</span></a></span> no synephrine was detected in juices from grapefruit, lime, or lemon.<span class="mw-ref" id="cite_ref-Av_16-1"><a href="#cite_note-Av-16" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>
 
<p>An analysis of the synephrine levels in a range of different citrus fruits, carried out on juices that had been extracted from fresh, peeled fruit, was reported by Uckoo and co-workers, with the following results:
Marrs sweet orange (<i>C. sinensis</i> Tan.): ~85<span>&nbsp;</span>mg/L; Nova tangerine (<i>C. reticulata</i> Tan.): ~78<span>&nbsp;</span>mg/L; clementine (<i>C. clementina</i> Tan.): ~115<span>&nbsp;</span>mg/L; Meyer lemon (<i>C. limon</i> Tan.) ~3<span>&nbsp;</span>mg/kg; Ugli tangelo (<i>C. reticulata</i> × <i>C. paradisi</i>) ~47<span>&nbsp;</span>mg/kg. No synephrine was detected in: Rio Red grapefruit (<i>C. paradisi</i> Macf.); Red-fleshed pummelo (<i>C. grandis</i> Tan.); or Wekiwa tangelo (<i>C. reticulata</i> × <i>C. paradisi</i>).<span class="mw-ref" id="cite_ref-XRef_17-1"><a href="#cite_note-XRef-17" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>Numerous additional comparable analyses of the synephrine content of <i>Citrus</i> fruits and products derived from them may be found in the research literature.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="In_humans_and_other_animals">In humans and other animals</h3></summary>
    
<p>Low levels of synephrine have been found in normal human urine,<span class="mw-ref" id="cite_ref-Ib_24-0"><a href="#cite_note-Ib-24" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> as well as in other mammalian tissue.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> To reduce the likelihood that the synephrine detected in urine had a dietary origin, the subjects tested by Ibrahim and co-workers abstained from the consumption of any citrus products for 48 hours prior to providing urine samples.<span class="mw-ref" id="cite_ref-Ib_24-1"><a href="#cite_note-Ib-24" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>A 2006 study of synephrine in human blood platelets by D'Andrea and co-workers showed increased levels in platelets from patients suffering from aura-associated migraine (0.72<span>&nbsp;</span>ng/10<sup>8</sup> platelets, compared to 0.33<span>&nbsp;</span>ng/10<sup>8</sup> platelets in control subjects).<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> Earlier, the same research group had reported a normal human blood plasma level of synephrine of 0.90–13.69<span>&nbsp;</span>ng/mL.<span class="mw-ref" id="cite_ref-Andrea_29-0"><a href="#cite_note-Andrea-29" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Stereoisomers">Stereoisomers</h3></summary>
    
<p>Since synephrine exists as either of two enantiomers (see Chemistry section below for further discussion), which do not produce identical biological effects (see Pharmacology section below) some researchers have examined the stereoisomeric composition of synephrine extracted from natural sources. Although it seems clear that synephrine is found in those <i>Citrus</i> species which have been studied predominantly as the l-isomer,<span class="mw-ref" id="cite_ref-Kusu_18-2"><a href="#cite_note-Kusu-18" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Pel_30-0"><a href="#cite_note-Pel-30" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> low levels of d-synephrine have been detected in juice and marmalade made from <i>C. unshiu</i>,<span class="mw-ref" id="cite_ref-Kusu_18-3"><a href="#cite_note-Kusu-18" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> and low levels (0.002%) have been reported in fresh fruit from <i>C. aurantium</i>.<span class="mw-ref" id="cite_ref-Pel_30-1"><a href="#cite_note-Pel-30" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> There are indications that some d-synephrine may be formed by the racemization of l-synephrine as a result of the processing of fresh fruit, although this matter has not been completely clarified.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> However, regardless of the situation in <i>Citrus</i> species, Ranieri and McLaughlin reported the <i>isolation</i> of racemic (i.e. a mixture of equal amounts of d- and l- stereoisomers) synephrine from a cactus of the genus <i>Dolichothele</i>, under conditions that would be unlikely to cause a significant amount of racemization.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Biosynthesis">Biosynthesis</h3></summary>
    
<p>The biosynthesis of synephrine in <i>Citrus</i> species is believed to follow the pathway: <a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">tyrosine</a> → <a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">tyramine</a> → <a href="N-Methyltyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-methyltyramine" title="N-methyltyramine" class="mw-redirect"><i>N</i>-methyltyramine</a> → synephrine, involving the enzymes tyrosine decarboxylase in the first step, tyramine <i>N</i>-methyltransferase in the second, and <i>N</i>-methyl-tyramine-β-hydroxylase in the third.<span class="mw-ref" id="cite_ref-Wheat_34-0"><a href="#cite_note-Wheat-34" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> This pathway differs from that thought to occur in animals, involving octopamine: tyramine → octopamine → synephrine, where the conversion of tyramine to octopamine is mediated by dopamine-β-hydroxylase, and the conversion of octopamine to synephrine by phenylethanolamine <i>N</i>-methyltransferase.<span class="mw-ref" id="cite_ref-Andrea_29-1"><a href="#cite_note-Andrea-29" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-Wheat_34-1"><a href="#cite_note-Wheat-34" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p><span>
</span><table role="presentation" cellpadding="0" style="border-spacing:0; margin-left: auto; margin-right: auto; border: none;">
<tbody><tr>
<td><div class="thumb center" style="margin: 1em auto;">
<div class="thumbinner" style="width:592px; ">
<div style="clear: both; font-weight: bold; font-size: 106.4%; text-align: center; background-color: #F0F8FF;margin-bottom:3px;">Biosynthetic pathways for catecholamines and trace amines in the human brain<span class="mw-ref" id="cite_ref-Trace_amine_template_1_36-0"><a href="#cite_note-Trace_amine_template_1-36" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-Trace_amine_template_2_37-0"><a href="#cite_note-Trace_amine_template_2-37" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-CYP2D6_tyramine-dopamine_metabolism_38-0"><a href="#cite_note-CYP2D6_tyramine-dopamine_metabolism-38" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></div>
<div style="position:relative; width:590px; height:585px; overflow:hidden; border:solid #ccc 1px; background-color:white;">
<div style="left:5px; top:0px; width:580px; position:absolute"> <figure-inline><img src="../I/m/Catecholamine_and_trace_amine_biosynthesis.png" tppabs="https://ptable.com/wiki/compounds/I/m/Catecholamine_and_trace_amine_biosynthesis.png" data-file-width="585" data-file-height="600" data-file-type="bitmap" height="595" width="580"></figure-inline>
</div> 
<div style="text-align:center; font-size:14px; line-height:110%;">
<div style="background-color:transparent; color:black"><div id="annotation_40x60" style="position:absolute; left:40px; top:60px;      line-height:110% "><span style="background-color:transparent; "><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine"><small>L</small>-Phenylalanine</a></span></div>
<div id="annotation_50x250" style="position:absolute; left:50px; top:250px;      line-height:110% "><span style="background-color:transparent; "><a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine"><small>L</small>-Tyrosine</a></span></div>
<div id="annotation_60x410" style="position:absolute; left:60px; top:410px;      line-height:110% "><span style="background-color:transparent; "><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA</a></span></div>
<div id="annotation_50x565" style="position:absolute; left:50px; top:565px;      line-height:110% "><span style="background-color:transparent; ">Epinephrine</span></div>

<div id="annotation_245x60" style="position:absolute; left:245px; top:60px;      line-height:110% "><span style="background-color:transparent; "><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></span></div>
<div id="annotation_245x250" style="position:absolute; left:245px; top:250px;      line-height:110% "><span style="background-color:transparent; "><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine"><i>p</i>-Tyramine</a></span></div>
<div id="annotation_245x410" style="position:absolute; left:245px; top:410px;      line-height:110% "><span style="background-color:transparent; "><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></span></div>
<div id="annotation_245x565" style="position:absolute; left:245px; top:565px;      line-height:110% "><span style="background-color:transparent; ">Norepinephrine</span></div>

<div id="annotation_430x60" style="position:absolute; left:430px; top:60px;      line-height:110% "><span style="background-color:transparent; "><a href="N-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methylphenethylamine" title="N-Methylphenethylamine"><i>N</i>-Methylphenethylamine</a></span></div>
<div id="annotation_440x150" style="position:absolute; left:440px; top:150px;      line-height:110% "><span style="background-color:transparent; "><a href="N-Methyltyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methyltyramine" title="N-Methyltyramine"><i>N</i>-Methyltyramine</a></span></div>
<div id="annotation_440x295" style="position:absolute; left:440px; top:295px;      line-height:110% "><span style="background-color:transparent; "><i>p</i>-Octopamine</span></div>
<div id="annotation_445x445" style="position:absolute; left:445px; top:445px;      line-height:110% "><span style="background-color:transparent; "><span style="background:yellow"><b>Synephrine</b></span></span></div>
<div id="annotation_425x565" style="position:absolute; left:425px; top:565px;      line-height:110% "><span style="background-color:transparent; "><a href="3-Methoxytyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a></span></div>

<div id="annotation_167x16" style="position:absolute; left:167px; top:16px;      line-height:110% "><span style="background-color:transparent; ">AADC</span></div>
<div id="annotation_167x203" style="position:absolute; left:167px; top:203px;      line-height:110% "><span style="background-color:transparent; ">AADC</span></div>
<div id="annotation_167x368" style="position:absolute; left:167px; top:368px;      line-height:110% "><span style="background-color:transparent; ">AADC</span></div>
<div id="annotation_164x386" style="position:absolute; left:164px; top:386px;   font-size:12px;   line-height:14px; "><span style="background-color:transparent; ">primary<br>pathway</span></div>

<div id="annotation_425x345" style="position:absolute; left:425px; top:345px;      line-height:110% "><span style="background-color:transparent; ">PNMT</span></div>
<div id="annotation_380x17" style="position:absolute; left:380px; top:17px;      line-height:110% "><span style="background-color:transparent; ">PNMT</span></div>
<div id="annotation_167x527" style="position:absolute; left:167px; top:527px;      line-height:110% "><span style="background-color:transparent; ">PNMT</span></div>
<div id="annotation_359x170" style="position:absolute; left:359px; top:170px;      line-height:110% "><span style="background-color:transparent; ">PNMT</span></div>

<div id="annotation_55x130" style="position:absolute; left:55px; top:130px;      line-height:110% "><span style="background-color:transparent; ">AAAH</span></div>
<div id="annotation_55x305" style="position:absolute; left:55px; top:305px;      line-height:110% "><span style="background-color:transparent; ">AAAH</span></div>
<div id="annotation_212x290" style="position:absolute; left:212px; top:290px;      line-height:110% "><span style="background-color:transparent; ">brain<br>CYP2D6</span></div>
<div id="annotation_274x290" style="position:absolute; left:274px; top:290px;   font-size:12px;   line-height:14px; text-align:left;"><span style="background-color:transparent; ">minor<br>pathway</span></div>
<div id="annotation_325x460" style="position:absolute; left:325px; top:460px;      line-height:110% "><span style="background-color:transparent; ">COMT</span></div>
<div id="annotation_235x460" style="position:absolute; left:235px; top:460px;      line-height:110% "><span style="background-color:transparent; ">DBH</span></div>
<div id="annotation_363x250" style="position:absolute; left:363px; top:250px;      line-height:110% "><span style="background-color:transparent; ">DBH</span></div></div>
</div>
</div>
<div class="thumbcaption" style="clear:left"><div style="float:left;margin-right:0.5em"><figure-inline><span><img src="../I/m/Interactive_icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Interactive_icon.svg.png" data-file-width="133" data-file-height="200" data-file-type="drawing" height="27" width="18"></span></figure-inline></div>In humans, catecholamines and phenethylaminergic trace amines are produced from the amino acid phenylalanine. Abbreviations:
DBH: Dopamine β-hydroxylase; AADC: Aromatic <small>L</small>-amino acid decarboxylase; AAAH: (Biopterin-dependent) aromatic amino acid hydroxylase; COMT: Catechol <i>O</i>-methyltransferase; PNMT: Phenylethanolamine <i>N</i>-methyltransferase</div>
</div>
</div></td></tr>
</tbody></table>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Presence_in_nutritional/dietary_supplements">Presence in nutritional/dietary supplements</h2></summary>
    
<p>Some dietary supplements, sold for the purposes of promoting weight-loss or providing energy, contain synephrine as one of several constituents. Usually, the synephrine is present as a natural component of <i>Citrus aurantium</i> ("bitter orange"), bound up in the plant matrix, but could also be of synthetic origin, or a purified phytochemical (i.e. extracted from a plant source and purified to chemical homogeneity).<span class="mw-ref" id="cite_ref-Blum_19-1"><a href="#cite_note-Blum-19" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-Sant_39-0"><a href="#cite_note-Sant-39" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> The concentration range found by Santana and co-workers in five different supplements purchased in the US was about 5–14<span>&nbsp;</span>mg/g.<span class="mw-ref" id="cite_ref-Sant_39-1"><a href="#cite_note-Sant-39" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmaceutical_use">Pharmaceutical use</h2></summary>
    
<p>As a synthetic drug, synephrine first appeared in Europe in the late 1920s, under the name of <i>Sympatol</i>. One of the earliest papers describing its pharmacological and toxicological properties was written by Lasch, who obtained it from the Viennese company Syngala.<span class="mw-ref" id="cite_ref-Las_41-0"><a href="#cite_note-Las-41" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> By 1930, <i>Sympatol</i> was referred to as a Boehringer product,<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> while one of the first US Patents describing its preparation and use was assigned to Frederick Stearns &amp; Co. in 1933.<span class="mw-ref" id="cite_ref-43"><a href="#cite_note-43" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> Despite the date of this patent, clinical and pharmacological research on synephrine obtained from Frederick Stearns &amp; Co was being carried out in the US by 1930.<span class="mw-ref" id="cite_ref-Stock_44-0"><a href="#cite_note-Stock-44" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-Tain_45-0"><a href="#cite_note-Tain-45" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> Writing in 1931, Hartung reported that in 1930 the Council on Pharmacy and Chemistry of the American Medical Association had accepted synephrine for inclusion in its list of “New and Non-Official Remedies” as an agent for the treatment, by either oral or parenteral administration, "of attacks of hay fever, asthma, coughing, spasms of asthma and pertussis (whooping cough)."<span class="mw-ref" id="cite_ref-46"><a href="#cite_note-46" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span><span class="mw-ref" id="cite_ref-Hart_47-0"><a href="#cite_note-Hart-47" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> However, synephrine was dropped from the Council's list in 1934, and its apparent re-advertising as a new drug by the Stearns company ten years later elicited a scathing comment from the Editors of the Journal of the American Medical Association.<span class="mw-ref" id="cite_ref-48"><a href="#cite_note-48" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> The third edition (1965) of <i>Drill's Pharmacology in Medicine</i> stated, with reservations, that synephrine was "advertised as an antihistaminic to be used in the treatment of the common cold...", under the trade name of "Synephrin Tartrate", and indicated that the dose was 100<span>&nbsp;</span>mg, given intramuscularly, or subcutaneously.<span class="mw-ref" id="cite_ref-49"><a href="#cite_note-49" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> Published in 1966, the <i>Textbook of Organic Medicinal and Pharmaceutical Chemistry</i> described synephrine (in the form of its racemic tartrate) as a sympathomimetic agent that was "less effective than epinephrine", and which had been used  for the treatment of chronic hypotension, collapse due to shock, and other conditions leading to hypotension.<span class="mw-ref" id="cite_ref-Wil_50-0"><a href="#cite_note-Wil-50" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> In a later (1972) textbook, synephrine was described as a drug, sold in Europe, that was administered in situations involving shock, such as surgical or bacteremic shock, and spinal anesthesia-related shock. The recommended dose was given here as 25–50<span>&nbsp;</span>mg, by intravenous, intramuscular or subcutaneous administration.<span class="mw-ref" id="cite_ref-51"><a href="#cite_note-51" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>

<p>There is no mention of synephrine in editions of <i>Drill's Pharmacology in Medicine</i> later than the 3rd, nor is there any reference to synephrine in the 2012 <i>Physicians' Desk Reference</i>, nor in the current FDA "Orange Book".</p>

<p>One current reference source describes synephrine as a vasoconstrictor that has been given to hypotensive patients, orally or by injection, in doses of 20–100<span>&nbsp;</span>mg.<span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>

<p>One website from a healthcare media company, accessed in February, 2013, refers to oxedrine as being indicated for hypotensive states, in oral doses of 100–150<span>&nbsp;</span>mg tid, and as a "conjunctival decongestant" to be topically applied as a 0.5% solution.<span class="mw-ref" id="cite_ref-53"><a href="#cite_note-53" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> However, no supporting references are provided.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Names">Names</h2></summary>
    
<p>There has been some confusion about the biological effects of synephrine because of the similarity of this un-prefixed name to the names <i>m-synephrine</i>, <i>Meta-synephrine</i> and <i>Neosynephrine</i>, all of which refer to a related drug and naturally-occurring amine more commonly known as <a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">phenylephrine</a>. Although there are chemical and pharmacological similarities between synephrine and phenylephrine, they are nevertheless different substances. The confusion is compounded by the fact that synephrine has been marketed as a drug under numerous different names, including <i>Sympatol</i>, <i>Sympathol</i>, <i>Synthenate</i>, and <i>oxedrine</i>, while phenylephrine has also been called <i>m-Sympatol</i>. The synephrine with which this article deals is sometimes referred to as <i>p-synephrine</i> in order to distinguish it from its positional isomers, <i>m</i>-synephrine and <i>o</i>-synephrine. A comprehensive listing of alternative names for synephrine may be found in the ChemSpider entry (see Chembox, at right). Confusion over the distinctions between <i>p</i>- and <i>m</i>-synephrine has even contaminated the primary research literature.<span class="mw-ref" id="cite_ref-56"><a href="#cite_note-56" style="counter-reset: mw-Ref 5;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 5]</span></a></span>
Even the name "<i>p</i>-synephrine" is not unambiguous, since it does not specify stereochemistry. The only completely unambiguous names for synephrine are: (<i>R</i>)-(−)-4-[1-hydroxy-2-(methylamino)ethyl]phenol (for the l-enantiomer); (<i>S</i>)-(+)-4-[1-hydroxy-2-(methylamino)ethyl]phenol (for the d-enantiomer); and (<i>R</i>,<i>S</i>)-4-[1-hydroxy-2-(methylamino)ethyl]phenol (for the racemate, or d,l-synephrine) (see <a href="#Chemistry" title="Synephrine">Chemistry</a> section).</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Properties">Properties</h3></summary>
    
<p>In terms of molecular structure, synephrine has a <a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">phenethylamine</a> skeleton, with a <a href="Phenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenol" title="Phenol">phenolic</a> hydroxy- group, an alcoholic hydroxy- group, and an <i>N</i>-methylated amino-group. Alternatively, synephrine might be described as a phenylethanolamine with an <i>N</i>-methyl and <i>p</i>-hydroxy substituent. The amino-group confers basic properties on the molecule, whereas the phenolic –OH group is weakly acidic: the apparent (see original article for discussion) pK<sub>a</sub>s for protonated synephrine are 9.55 (phenolic H) and 9.79 (ammonium H).<span class="mw-ref" id="cite_ref-57"><a href="#cite_note-57" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>

<p>Common salts of racemic synephrine are its hydrochloride, C<sub>9</sub>H<sub>13</sub>NO<sub>2</sub>.HCl, m.p.<span>&nbsp;</span>150–152°,<span class="mw-ref" id="cite_ref-58"><a href="#cite_note-58" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> the <a href="Oxalate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxalate" title="Oxalate">oxalate</a> (C<sub>9</sub>H<sub>13</sub>NO<sub>2</sub>)<sub>2</sub>.C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>, m.p.<span>&nbsp;</span>221–222<span>&nbsp;</span>°C,<span class="mw-ref" id="cite_ref-Stew_4-1"><a href="#cite_note-Stew-4" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> and the tartrate (Sympatol), (C<sub>9</sub>H<sub>13</sub>NO<sub>2</sub>)<sub>2</sub>.C<sub>4</sub>H<sub>6</sub>O<sub>6</sub>, m.p.<span>&nbsp;</span>188–190<span>&nbsp;</span>°C.<span class="mw-ref" id="cite_ref-Wil_50-1"><a href="#cite_note-Wil-50" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-59"><a href="#cite_note-59" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span></p>

<p>The presence of the hydroxy-group on the benzylic C of the synephrine molecule creates a chiral center, so the compound exists in the form of two enantiomers, d- and l- synephrine, or as the racemic mixture, d,l- synephrine. The dextrorotatory d-isomer corresponds to the (<i>S</i>)-configuration, and the levorotatory l-isomer to the (<i>R</i>)-configuration.<span class="mw-ref" id="cite_ref-Midg_60-0"><a href="#cite_note-Midg-60" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>

<p>Racemic synephrine has been resolved using ammonium 3-bromo-camphor-8-sulfonate.<span class="mw-ref" id="cite_ref-Pellat_12-1"><a href="#cite_note-Pellat-12" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Midg_60-1"><a href="#cite_note-Midg-60" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> The enantiomers were not characterized as their free bases, but converted to the hydrochloride salts, with the following properties:<span class="mw-ref" id="cite_ref-Midg_60-2"><a href="#cite_note-Midg-60" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>

<p>(<i>S</i>)-(+)-C<sub>9</sub>H<sub>13</sub>NO<sub>2</sub>.HCl: m.p.<span>&nbsp;</span>178<span>&nbsp;</span>°C; [α] = +42.0°, c 0.1 (H<sub>2</sub>O); (<i>R</i>)-(−)-C<sub>9</sub>H<sub>13</sub>NO<sub>2</sub>.HCl: m.p.<span>&nbsp;</span>176<span>&nbsp;</span>°C; [α] = −39.0°, c 0.2 (H<sub>2</sub>O)</p>

<p>(−)-Synephrine, as the free base isolated from a <i>Citrus</i> source, has m.p.<span>&nbsp;</span>162–164<span>&nbsp;</span>°C (with decomposition).<span class="mw-ref" id="cite_ref-Stew_4-2"><a href="#cite_note-Stew-4" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Stew2_5-1"><a href="#cite_note-Stew2-5" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>The X-ray structure for synephrine has been determined.<span class="mw-ref" id="cite_ref-Midg_60-3"><a href="#cite_note-Midg-60" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Synthesis">Synthesis</h3></summary>
    
<p>Early and seemingly inefficient syntheses of synephrine were discussed by Priestley and Moness, writing in 1940.<span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> These chemists optimized a route beginning with the <i>O</i>-benzoylation of <i>p</i>-hydroxy-phenacyl chloride, followed by reaction of the resulting <i>O</i>-protected chloride with <i>N</i>-methyl-benzylamine to give an amino-ketone. This intermediate was then hydrolyzed with HCl/alcohol to the <i>p</i>-hydroxy-aminoketone, and the product then reduced catalytically to give (racemic) synephrine.</p>

<p>A later synthesis, due to Bergmann and Sulzbacher, began with the <i>O</i>-benzylation of <i>p</i>-hydroxy-benzaldehyde, followed by a Reformatskii reaction of the protected aldehyde with ethyl bromoacetate/Zn to give the expected β-hydroxy ester. This intermediate was converted to the corresponding acylhydrazide with hydrazine, then the acylhydrazide reacted with HNO<sub>2</sub>, ultimately yielding the <i>p</i>-benzyloxy-phenyloxazolidone. This was <i>N</i>-methylated using <a href="Dimethyl_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethyl_sulfate" title="Dimethyl sulfate">dimethyl sulfate</a>, then hydrolyzed and <i>O</i>-debenzylated by heating with HCl, to give racemic synephrine.<span class="mw-ref" id="cite_ref-62"><a href="#cite_note-62" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Structural_relationships">Structural relationships</h3></summary>
    
<p>Much reference has been made in the literature (both lay and professional) of the structural kinship of synephrine with <a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">ephedrine</a>, or with <a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">phenylephrine</a>, often with the implication that the perceived similarities in structure should result in similarities in pharmacological properties. However, from a chemical perspective, synephrine is also related to a very large number of other drugs whose structures are based on the phenethylamine skeleton, and although some properties are common, others are not, making unqualified comparisons and generalizations inappropriate.</p>

<p>Thus, replacement of the <i>N</i>-methyl group in synephrine with a hydrogen atom gives octopamine; replacement of the β-hydroxy group in synephrine by a H atom gives <a href="N-Methyltyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-methyltyramine" title="N-methyltyramine" class="mw-redirect"><i>N</i>-methyltyramine</a>; replacement of the synephrine <a href="Phenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenol" title="Phenol">phenolic</a> 4-OH group by a –H gives halostachine.</p>

<p>If the synephrine phenolic 4-OH group is shifted to the <i>meta</i>-, or 3-position on the benzene ring, the compound known as phenylephrine (or <i>m</i>-synephrine, or "Neo-synephrine") results; if the same group is shifted to the <i>ortho</i>-, or 2-position on the ring, <i>o</i>-synephrine results.</p>

<p>Addition of another phenolic –OH group to the 3-position of the benzene ring produces the neurotransmitter <a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">epinephrine</a>; addition of a methyl group to the α-position in the side-chain of synephrine gives oxilofrine (methylsynephrine). Four stereoisomers (two pairs of enantiomers) are possible for this substance.</p>

<p>Extension of the synephrine <i>N</i>-methyl substituent by one methylene unit to an <i>N</i>-<a href="Ethyl_group.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethyl_group" title="Ethyl group">ethyl</a> gives the hypotensive experimental drug "Sterling #573"/"Aethyl-Sympatol".<span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-64"><a href="#cite_note-64" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span></p>

<p>The above structural relationships all involve a change at <i>one</i> position in the synephrine molecule, and numerous other similar changes, many of which have been explored, are possible. However, the structure of ephedrine differs from that of synephrine at <i>two</i> different positions: ephedrine has no substituent on the phenyl ring where synephrine has a 4-OH group, and ephedrine has a methyl group on the position α- to the N in the side-chain, where syneprine has only a H atom. Furthermore, "synephrine" exists as either of two enantiomers, while "ephedrine" exists as one of four different enantiomers; there are, in addition, racemic mixtures of these enantiomers.</p>

<p>The main differences of the synephrine isomers compared for example to the <a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">ephedrines</a> are the hydroxy-substitutions on the benzene ring. Synephrines are direct sympathomimetic drugs while the ephedrines are both direct and indirect sympathomimetics. One of the main reasons for these differential effects is the obviously increased polarity of the hydroxy-substituted phenyl ethyl amines which renders them less able to penetrate the blood-brain barrier as illustrated in the examples for tyramine and the amphetamine analogs.<span class="mw-ref" id="cite_ref-65"><a href="#cite_note-65" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Synopsis">Synopsis</h3></summary>
    
<p>Classical pharmacological studies on animals and isolated animal tissues showed that the principal actions of parenterally-administered synephrine included raising blood-pressure, dilating the pupil, and constricting peripheral blood vessels.</p>

<p>There is now ample evidence<sup>(what evidence?)</sup> that synephrine produces most of its biological effects by acting as an agonist (i.e. stimulating) at adrenergic receptors, with a distinct preference for the α<sub>1</sub> over the  α<sub>2</sub> sub-type. However, the potency of synephrine at these receptors is relatively low (i.e. relatively large concentrations of the drug are required to activate them). The potency of synephrine at adrenergic receptors of the β-class (regardless of sub-type) is much lower than at α-receptors. There is some evidence that synephrine also has weak activity at 5-HT receptors, and that it interacts with TAAR1 (trace amine-associated receptor 1).</p>

<p>In common with virtually all other simple phenylethanolamines (β-hydroxy-phenethylamines), the (<i>R</i>)-(−)-, or l-, enantiomer of synephrine is more potent than the (<i>S</i>)-(+)-, or d-, enantiomer in most, but not all preparations studied. However, the majority of studies have been conducted with a racemic mixture of the two enantiomers.</p>

<p>Since the details regarding such variables as test species, receptor source, route of administration, drug concentration, and stereochemical composition are important but often incomplete in other Reviews and Abstracts of research publications, many are provided in the more technical review below, in order to support as fully as possible the broad statements made in this Synopsis.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacology_research">Pharmacology research</h3></summary>
    
<p>Pharmacological studies on synephrine date back to the late 1920s, when it was observed that injected synephrine raised blood pressure, constricted peripheral blood vessels, dilated pupils, stimulated the uterus, and relaxed the intestines in experimental animals.<span class="mw-ref" id="cite_ref-Las_41-1"><a href="#cite_note-Las-41" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-Las_41-2"><a href="#cite_note-Las-41" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-66"><a href="#cite_note-66" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span><span class="mw-ref" id="cite_ref-67"><a href="#cite_note-67" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> Representative of this early work is the paper by Tainter and Seidenfeld, who were the first researchers to systematically compare the different effects of the two synephrine enantiomers, d- and l- synephrine, as well as of the racemate, d,l-synephrine, in various animal assays.<span class="mw-ref" id="cite_ref-Tain_45-1"><a href="#cite_note-Tain-45" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span>
In experiments on anesthetized cats, Tainter and Seidenfeld confirmed earlier reports of the increase in blood pressure produced by intravenous doses of synephrine, showing that the median pressor doses for the isomers were: l-synephrine: 0.5<span>&nbsp;</span>mg/kg; d,l-synephrine: 1.0<span>&nbsp;</span>mg/kg; and d-synephrine: 2–20<span>&nbsp;</span>mg/kg. These effects lasted 2–3 minutes, peaking at ~30 seconds after administration. l-Synephrine was thus the more potent enantiomer, with about 1/60x the potency of the standard pressor l-epinephrine in the same assay.
A later study, by Lands and Grant, showed that a dose of ~0.6<span>&nbsp;</span>mg/kg of racemic synephrine, given intravenously to anesthetized dogs, produced a rise in blood pressure of 34<span>&nbsp;</span>mmHg lasting 5–10 minutes, and estimated that this pressor activity was about 1/300x that of epinephrine.<span class="mw-ref" id="cite_ref-Lands_68-0"><a href="#cite_note-Lands-68" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span></p>

<p>Using cats and dogs, Tainter and Seidenfeld observed that neither d- nor l-synephrine caused any changes in the tone of normal bronchi, <i>in situ</i>, even at "maximum" doses. Furthermore, the marked brocho-constriction produced by injections of <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">histamine</a> was not reversed by either l-synephrine  or d,l-synephrine.<span class="mw-ref" id="cite_ref-Tain_45-2"><a href="#cite_note-Tain-45" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>In experiments with isolated sheep carotid artery, d-, l- and d,l-synephrine all showed some vasoconstrictor activity: l-synephrine was the most potent, producing strong contractions at a concentration of 1:10000.<span class="mw-ref" id="cite_ref-69"><a href="#cite_note-69" style="counter-reset: mw-Ref 6;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 6]</span></a></span> d-Synephrine was about 1/2 as potent as the l-isomer, but d,l-synephrine (which would have been expected to have a potency of 1/2 that of l-synephrine even if the d-isomer were completely inactive) did not produce significant and irregular contractions until a concentration of 1:2500<span class="mw-ref" id="cite_ref-70"><a href="#cite_note-70" style="counter-reset: mw-Ref 7;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 7]</span></a></span>had been reached, implying an inhibitory interaction between the two enantiomers.<span class="mw-ref" id="cite_ref-Tain_45-3"><a href="#cite_note-Tain-45" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>Qualitatively similar results were obtained in a rabbit ear preparation: 25<span>&nbsp;</span>mg l-synephrine produced significant (50%) vasoconstriction, while the same concentration of d-synephrine elicited essentially no response. In contrast, d,l-synephrine did not produce any constriction up to 25<span>&nbsp;</span>mg, but 25 – 50<span>&nbsp;</span>mg caused a relaxation of the blood vessels, which again suggested that the d-isomer might be inhibiting the action of the l-isomer.<span class="mw-ref" id="cite_ref-Tain_45-4"><a href="#cite_note-Tain-45" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>Experiments on strips of rabbit duodenum showed that l-synephrine caused a modest reduction in contractions at a concentration of 1:17000,<span class="mw-ref" id="cite_ref-71"><a href="#cite_note-71" style="counter-reset: mw-Ref 8;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 8]</span></a></span> but that the effects of the d- and d,l- forms were much weaker.<span class="mw-ref" id="cite_ref-Tain_45-5"><a href="#cite_note-Tain-45" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>Racemic synephrine, given intramuscularly, or by instillation, was found to significantly reduce the inflammation caused by instillation of <a href="Mustard_oil.htm" tppabs="https://ptable.com/wiki/compounds/A/Mustard_oil" title="Mustard oil">mustard oil</a> into the eyes of rabbits.<span class="mw-ref" id="cite_ref-Tain_45-6"><a href="#cite_note-Tain-45" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>Subcutaneous injection of racemic synephrine into rabbits was reported to cause a large rise in blood sugar.<span class="mw-ref" id="cite_ref-Hart_47-1"><a href="#cite_note-Hart-47" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>

<p>In experiments on anesthetized cats, Papp and Szekeres found that synephrine (stereochemistry unspecified) raised the thresholds for auricular and ventricular fibrillation, an indication of anti-arrhythmic properties.<span class="mw-ref" id="cite_ref-72"><a href="#cite_note-72" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></p>

<p>Evidence that synephrine might have some central effects comes from the research of Song and co-workers, who studied the effects of synephrine in mouse models<span class="mw-ref" id="cite_ref-73"><a href="#cite_note-73" style="counter-reset: mw-Ref 9;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 9]</span></a></span> of anti-depressant activity.<span class="mw-ref" id="cite_ref-74"><a href="#cite_note-74" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> These researchers observed that oral doses of 0.3 – 10<span>&nbsp;</span>mg/kg of racemic synephrine were effective in shortening the duration of immobility<span class="mw-ref" id="cite_ref-75"><a href="#cite_note-75" style="counter-reset: mw-Ref 10;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 10]</span></a></span> produced in the assays, but did not cause any changes in spontaneous motor activity in separate tests. This characteristic immobility could be counteracted by the pre-administration of <a href="Prazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prazosin" title="Prazosin">prazosin</a>.<span class="mw-ref" id="cite_ref-76"><a href="#cite_note-76" style="counter-reset: mw-Ref 11;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 11]</span></a></span>
Subsequent experiments using the individual enanatiomers of synephrine revealed that although the d-isomer significantly reduced the duration of immobility in the tail suspension test, at an oral dose of 3<span>&nbsp;</span>mg/kg, the l-isomer had no effect at the same dose.
In mice pre-treated with <a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">reserpine</a>,<span class="mw-ref" id="cite_ref-77"><a href="#cite_note-77" style="counter-reset: mw-Ref 12;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 12]</span></a></span> an oral dose of 0.3<span>&nbsp;</span>mg/kg d-synephrine significantly reversed the hypothermia, while l-synephrine required a dose of 1<span>&nbsp;</span>mg/kg to be effective.
Experiments with slices of cerebral cortex taken from rat brain showed that d-synephrine inhibited the uptake of [<sup>3</sup>H]-norepinephrine with an IC<sub>50</sub> = 5.8 μM; l-synephrine was less potent (IC<sub>50</sub> = 13.5 μM).
d-Synephrine also competitively inhibited the binding of nisoxetine<span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 13;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 13]</span></a></span> to rat brain cortical slices, with a K<sub>i</sub> = 4.5 μM; l-synephrine was less potent (K<sub>i</sub> = 8.2 μM).
In experiments on the release of [<sup>3</sup>H]-norepinephrine from rat brain cortical slices, however, the l-isomer of synephrine was a more potent enhancer of the release (EC<sub>50</sub> = 8.2 μM) than the d-isomer (EC<sub>50</sub> = 12.3 μM). This enhanced release by l-synephrine was blocked by nisoxetine.<span class="mw-ref" id="cite_ref-79"><a href="#cite_note-79" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></p>

<p>Burgen and Iversen, examining the effect of a broad range of phenethylamine-based drugs on [<sup>14</sup>C]-norepinephrine-uptake in the isolated rat heart, observed that racemic synephrine<span class="mw-ref" id="cite_ref-80"><a href="#cite_note-80" style="counter-reset: mw-Ref 14;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 14]</span></a></span> was a relatively weak inhibitor (IC<sub>50</sub> = 0.12 μM) of the uptake.<span class="mw-ref" id="cite_ref-81"><a href="#cite_note-81" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span></p>

<p>Another receptor-oriented study by Wikberg revealed that synephrine (stereochemistry unspecified) was a more potent agonist at guinea pig aorta α<sub>1</sub> receptors (pD<sub>2</sub> = 4.81) than at ileum α<sub>2</sub> receptors (pD<sub>2</sub> = 4.48), with a relative affinity ratio of α<sub>2</sub>/α<sub>1</sub> = 0.10. Although clearly indicating a selectivity of synephrine for α<sub>1</sub> receptors, its potency at this receptor sub-class is still relatively low, in comparison with that of phenylephrine (pD<sub>2</sub> at α<sub>1</sub> = 6.32).<span class="mw-ref" id="cite_ref-82"><a href="#cite_note-82" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span></p>

<p>Brown and co-workers examined the effects of the individual enantiomers of synephrine on α<sub>1</sub> receptors in rat aorta, and on α<sub>2</sub> receptors in rabbit saphenous vein. In the aorta preparation, l-synephrine gave a pD<sub>2</sub> = 5.38 (potency relative to norepinephrine = 1/1000), while d-synephrine had a pD<sub>2</sub> = 3.50 (potency relative to norepinephrine = 1/50000); in comparison, l-phenylephrine had pD<sub>2</sub> = 7.50 (potency relative to norepinephrine ≃ 1/6). No antagonism of norepinephrine was produced by concentrations of l-synephrine up to 10<sup>−6</sup> M. In the rabbit saphenous assay, the pD<sub>2</sub> of l-synephrine was 4.36 (potency relative to norepinephrine ≃ 1/1700), and that of d-synephrine was &lt; 3.00; in comparison, l-phenylephrine had pD<sub>2</sub> = 5.45 (potency relative to norepinephrine ≃ 1/140). No antagonism of norepinephrine was produced by concentrations of l-synephrine up to 10<sup>−5</sup> M.<span class="mw-ref" id="cite_ref-Brown_83-0"><a href="#cite_note-Brown-83" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span></p>

<p>A study of the effects of synephrine (stereochemistry unspecified) on strips of guinea pig aorta and on the field-stimulated guinea pig ileum showed that synephrine had an agonist potency of −logK<sub>a</sub> = 3.75 in the aorta assay. In comparison, epinephrine had a potency of −logK<sub>a</sub> = 5.70. There was no significant effect on the ileum at synephrine concentrations up to about 2 × 10<sup>−4</sup> M, indicating selectivity for the α<sub>1</sub> receptor, but relatively low potency.<span class="mw-ref" id="cite_ref-84"><a href="#cite_note-84" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></p>

<p>In binding experiments with central adrenergic receptors, using a preparation from rat cerebral cortex, l-synephrine had pIC<sub>50</sub> = 3.35, and d-synephrine had pIC<sub>50</sub> = 2.42 in competition against [<sup>3</sup>H]-<a href="Prazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prazosin" title="Prazosin">prazosin</a> (standard α<sub>1</sub> ligand); against [<sup>3</sup>H]-<a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">yohimbine</a> (standard α<sub>2</sub> ligand), l-synephrine showed a pIC<sub>50</sub> = 5.01, and d-synephrine showed a pIC<sub>50</sub> = 4.17.<span class="mw-ref" id="cite_ref-Brown_83-1"><a href="#cite_note-Brown-83" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span></p>

<p>Experiments conducted by Hibino and co-workers also showed that synephrine (stereochemistry unspecified) produced a dose-dependent constriction of isolated rat aorta strips, in the concentration range 10<sup>−5</sup>–3 × 10<sup>−6</sup> M. This constriction was found to be competitively antagonized by prazosin (a standard α<sub>1</sub> antagonist) and <a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">ketanserin</a>,<span class="mw-ref" id="cite_ref-85"><a href="#cite_note-85" style="counter-reset: mw-Ref 15;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 15]</span></a></span> with prazosin being the more potent antagonist (pA<sub>2</sub> = 9.38, vs pA<sub>2</sub> = 8.23 for ketanserin). Synephrine constrictions were also antagonized by BRL-15,572{{Used here as a selective 5-HT<sub>1D</sub> antagonist.}}, but not by SB-216,641 (used here as a selective 5-HT<sub>1B</sub> antagonist), or by <a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">propranolol</a> (a common β antagonist).<span class="mw-ref" id="cite_ref-86"><a href="#cite_note-86" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span></p>

<p>In studies on guinea pig atria and trachea, Jordan and co-workers also found that synephrine had negligible activity on β<sub>1</sub> and β<sub>2</sub> receptors, being about 40000x less potent than norepinephrine.<span class="mw-ref" id="cite_ref-87"><a href="#cite_note-87" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span></p>

<p>Experiments with cultured white fat cells from several animal species, including human, by Carpéné and co-workers showed that racemic synephrine produced lipolytic effects, but only at high concentrations (0.1-1 mM). The potency, expressed in terms of pD<sub>2</sub> of synephrine in these species was as follows: rat: 4.38; hamster: 5.32; guinea pig: 4.31; human: 4.94. In comparison, <a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">isoprenaline</a> had a pD<sub>2</sub> = 8.29 and norepinephrine had pD<sub>2</sub> = 6.80 in human white fat cells. The lipolytic effect of 1 mM/L of synephrine on rat white fat cells was antagonized by various β-antagonists with the following inhibitory concentrations (IC<sub>50</sub>): bupranolol:<span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 16;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 16]</span></a></span> 0.11 μM; CGP-20,712A (β<sub>1</sub> antagonist): 6.09 μM; ICI-118,551 (β<sub>2</sub> antagonist): 3.58 μM; SR-5923A (β<sub>3</sub> antagonist): 17 μM.<span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span></p>

<p>The binding of racemic synephrine to cloned human adrenergic receptors has been examined: Ma and co-workers found that synephrine bound to α<sub>1A</sub>, α<sub>2A</sub> and α<sub>2C</sub> with low affinity (pK<sub>i</sub> = 4.11 for α<sub>1A</sub>; 4.44 for α<sub>2A</sub>; 4.61 for α<sub>2C</sub>). Synephrine behaved as a partial agonist at α<sub>1A</sub> receptors, but as an antagonist at α<sub>2A</sub> and α<sub>2C</sub> sub-types.<span class="mw-ref" id="cite_ref-90"><a href="#cite_note-90" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span></p>

<p>Racemic synephrine has been shown to be an agonist of the TAAR1,<span class="mw-ref" id="cite_ref-pmid15860375_91-0"><a href="#cite_note-pmid15860375-91" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> although its potency at the human TAAR1 is relatively low (EC<sub>50</sub> = 23700 nM; E<sub>max</sub> = 81.2%).<span class="mw-ref" id="cite_ref-92"><a href="#cite_note-92" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    
<p>The pharmacokinetics of synephrine were studied by Hengstmann and Aulepp, who reported a peak plasma concentration at 1–2 hours, with an elimination half-life (T<sub>1/2</sub>) of ~ 2 hours.<span class="mw-ref" id="cite_ref-93"><a href="#cite_note-93" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Metabolism">Metabolism</h2></summary>
    
<p>Studies of the metabolism of synephrine by monoamine oxidases derived from rat brain mitochondria showed that synephrine was a substrate for deamination by both MAO-A and MAO-B, with K<sub>m</sub> = 250 μM and V<sub>max</sub> = 32.6 nM/mg protein/30 minutes; there was some evidence for preferential deamination by MAO-A.<span class="mw-ref" id="cite_ref-94"><a href="#cite_note-94" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Effects_in_humans">Effects in humans</h2></summary>
    
<span>

</span>
<p>A number of studies of the effects of synephrine in humans, most of them focusing on its cardiovascular properties, have been performed since its introduction as a synthetic drug around 1930.<span class="mw-ref" id="cite_ref-Stock_44-1"><a href="#cite_note-Stock-44" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-95"><a href="#cite_note-95" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span><span class="mw-ref" id="cite_ref-96"><a href="#cite_note-96" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span><span class="mw-ref" id="cite_ref-97"><a href="#cite_note-97" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-98"><a href="#cite_note-98" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span><span class="mw-ref" id="cite_ref-Hoff_99-0"><a href="#cite_note-Hoff-99" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> The paper by Stockton and co-workers is representative, describing the effects of racemic synephrine in humans with particular attention to differences resulting from different routes of administration. Thus, it was shown by these investigators that <i>intramuscular</i> injections (average effective dose = 200<span>&nbsp;</span>mg) of the drug produced an increase in systolic blood pressure and pulse rate, without affecting the diastolic pressure. The blood pressure increase reached a maximum (~25<span>&nbsp;</span>mmHg) in 5 minutes following the injection, then gradually returned to normal over the course of 1 hour. Doses of drug greater than 200<span>&nbsp;</span>mg caused side-effects such as heart palpitations, headache, sweating, and feelings of apprehension. When given <i>intravenously</i>, doses of 25–50<span>&nbsp;</span>mg sufficed to produce a mean maximum increase in the blood pressure of 29<span>&nbsp;</span>mmHg in 2 minutes, and a return to baseline within 30 minutes. Respiration was generally not affected during these experiments. <i>Subcutaneous</i> administration of synephrine in doses ≤ 200<span>&nbsp;</span>mg had no effects on blood pressure or pulse rate. <i>Oral</i> doses of 500–1500<span>&nbsp;</span>mg of the drug did not affect blood pressure or respiration, but pulse rate was increased by ~12%, and the highest doses caused nausea and vomiting.<span class="mw-ref" id="cite_ref-Stock_44-2"><a href="#cite_note-Stock-44" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>

<p>The i.m. administration of 75–500<span>&nbsp;</span>mg of synephrine did not relieve acute asthma attacks, contradicting an earlier claim.<span class="mw-ref" id="cite_ref-100"><a href="#cite_note-100" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> However, the topical application of 1–3% solutions of the drug to the nasal mucosa of patients with sinusitis did produce a beneficial constriction without local irritation.<span class="mw-ref" id="cite_ref-Stock_44-3"><a href="#cite_note-Stock-44" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>

<p>A more recent study showed that the administration of synephrine by continuous intravenous infusion, at the rate of 4<span>&nbsp;</span>mg/minute, significantly increased mean arterial and systolic pressure, but diastolic pressure and heart rate were unaltered.;<span class="mw-ref" id="cite_ref-Hoff_99-1"><a href="#cite_note-Hoff-99" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> further details of this investigation are summarized in a review by Fugh-Berman and Myers.<span class="mw-ref" id="cite_ref-101"><a href="#cite_note-101" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span></p>

<p>There are a number of studies, references to many of which may be found in the review by Stohs and co-workers.<span class="mw-ref" id="cite_ref-Stohs_102-0"><a href="#cite_note-Stohs-102" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span> dealing with the effects produced by dietary supplements and herbal medications that contain synephrine as only one of many different chemical ingredients. These are outside the scope of the present article (see also the "<a href="#Safety/Efficacy/Controversy" title="Synephrine">Safety/Efficacy/Controversy</a>" sub-section).</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Toxicology">Toxicology</h2></summary>
    
<p>The acute toxicities of racemic synephrine in different animals, reported in terms of "maximum tolerated dose" after s.c administration, were as  follows: mouse: 300<span>&nbsp;</span>mg/kg; rat: 400<span>&nbsp;</span>mg/kg; guinea pig: 400<span>&nbsp;</span>mg/kg. "Lethal doses", given s.c., were found to be: mouse: 400<span>&nbsp;</span>mg/kg; rat: 500<span>&nbsp;</span>mg/kg; guinea pig: 500<span>&nbsp;</span>mg/kg.<span class="mw-ref" id="cite_ref-Las_41-3"><a href="#cite_note-Las-41" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> Another study of this compound,<span class="mw-ref" id="cite_ref-103"><a href="#cite_note-103" style="counter-reset: mw-Ref 17;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 17]</span></a></span> administered i.v. in mice, gave an LD<sub>50</sub> = 270<span>&nbsp;</span>mg/kg.<span class="mw-ref" id="cite_ref-Lands_68-1"><a href="#cite_note-Lands-68" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span></p>

<p>The "subchronic toxicity" of synephrine was judged to be low in mice, after administration of oral doses of 30 and 300<span>&nbsp;</span>mg/kg over a period of 28 days, in a recent study employing modern methodology carried out by Arbo and co-workers. Generally, this treatment did not result in significant alterations in biochemical or hematological parameters, nor in relative organ weights, but some changes were noted in <a href="Glutathione.htm" tppabs="https://ptable.com/wiki/compounds/A/Glutathione" title="Glutathione">glutathione</a> (GSH) concentration, and in the activity of glutathione peroxidase (GPx).<span class="mw-ref" id="cite_ref-104"><a href="#cite_note-104" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Safety/efficacy/controversy">Safety/efficacy/controversy</h2></summary>
    
<p>Information about the safety and efficacy of synephrine used as a single drug may be deduced from the foregoing review of the literature in this Article. This information is, by and large, not contended. However, there exists considerable controversy about the safety and/or efficacy of <i>synephrine-containing preparations</i>, which are often confused with synephrine alone, sometimes with <i>m</i>-synephrine, and much has been written about such preparations in the medical literature and on the Internet.<span class="mw-ref" id="cite_ref-Blum_19-2"><a href="#cite_note-Blum-19" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-G._Rossato,_V._M_2011_54-1"><a href="#cite_note-G._Rossato,_V._M_2011-54" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-Stohs_102-1"><a href="#cite_note-Stohs-102" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span><span class="mw-ref" id="cite_ref-105"><a href="#cite_note-105" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span><span class="mw-ref" id="cite_ref-106"><a href="#cite_note-106" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span><span class="mw-ref" id="cite_ref-107"><a href="#cite_note-107" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-108"><a href="#cite_note-108" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span><span class="mw-ref" id="cite_ref-109"><a href="#cite_note-109" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span><span class="mw-ref" id="cite_ref-110"><a href="#cite_note-110" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span><span class="mw-ref" id="cite_ref-111"><a href="#cite_note-111" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span><span class="mw-ref" id="cite_ref-112"><a href="#cite_note-112" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span><span class="mw-ref" id="cite_ref-113"><a href="#cite_note-113" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span> Since this body of literature deals with mixtures containing synephrine as only one of several biologically-active components, even, in some cases, without explicit confirmation of the presence of synephrine, further discussion is outside the scope of this article.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Invertebrates">Invertebrates</h2></summary>
    
<p>In insects, synephrine has been found to be a very potent agonist at many invertebrate octopamine receptor preparations, and is even more potent than octopamine at a locust (<i>Schistocerca americana gregaria</i>) nerve-muscle preparation.<span class="mw-ref" id="cite_ref-114"><a href="#cite_note-114" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> Synephrine (racemic) is also more potent than octopamine (racemic) at inducing light-emission in the firefly (<i>Photinus</i> species) light organ.<span class="mw-ref" id="cite_ref-115"><a href="#cite_note-115" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> Synephrine exhibits similarly high potency in stimulating adenylate cyclase activity and in decreasing clotting time in lobster (<i>Homarus americanus</i>) hematocytes.<span class="mw-ref" id="cite_ref-116"><a href="#cite_note-116" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span> Racemic synephrine was found to increase <a href="Cyclic_adenosine_monophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cAMP</a> in the abdominal epidermis of the blood-sucking bug, <i>Rhodnius prolixus</i>.<span class="mw-ref" id="cite_ref-117"><a href="#cite_note-117" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> Rachinsky reported that synephrine was equipotent with octopamine in stimulating JH (juvenile hormone) release in the corpora allata of honey bee (<i>Apis mellifera</i>),<span class="mw-ref" id="cite_ref-118"><a href="#cite_note-118" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span> but Woodring and Hoffmann found that synephrine had no effect on the synthesis of JH III, in <i>in vitro</i> preparations from the cricket, <i>Gryllus bimaculatus</i>.<span class="mw-ref" id="cite_ref-119"><a href="#cite_note-119" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Footnotes">Footnotes</h2></summary>
    
<div class="reflist " style=" list-style-type: lower-alpha;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references" data-mw-group="lower-alpha"><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text">Synephrine does however not appear in the current FDA "Orange Book" or the 2012 <i>Physicians' Desk Reference</i>.</span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text">About 1.0–0.02 mg/serving, based on a serving size of ~20g.</span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text">About 1.0–0.1 mg/serving.</span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text">Corresponding to roughly 1–15 mg/serving, assuming a 1-cup or 250 mL serving size.</span></li><li id="cite_note-56"> <span id="mw-reference-text-cite_note-56" class="mw-reference-text">For example, a recent review paper concerning the use of synephrine-containing nutritional supplements states that: "There is no consensus regarding which synephrine’s positional isomers are present in CA [<i>Citrus aurantium</i>]. The majority of authors state that only <i>p</i>-synephrine can be found in CA fruits...although others claim that <i>m</i>-synephrine is also present..."<span class="mw-ref" id="cite_ref-G._Rossato,_V._M_2011_54-0"><a href="#cite_note-G._Rossato,_V._M_2011-54" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> However, an examination of the references cited in support of this statement show that all the evidence for the presence of <i>m</i>-synephrine in <i>C. aurantium</i> derives from a report by Penzak and co-workers,<span class="mw-ref" id="cite_ref-55"><a href="#cite_note-55" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> whose Abstract states that <i>m</i>-synephrine was found in <i>C. aurantium</i>, whereas a close reading of the text of the paper itself reveals that the authors (although apparently uncertain about which synephrine regio-isomer had been found in the plant by earlier investigators) were aware that their analytical technique could not distinguish between <i>m</i>- and <i>p</i>-synephrine, and did <i>not</i> claim that <i>m</i>-synephrine was present. Thus the Abstract is at variance with the experimental findings given in the full text of the paper, but this error has propagated through subsequent publications.</span></li><li id="cite_note-69"> <span id="mw-reference-text-cite_note-69" class="mw-reference-text">~ 5 x 10<sup>−4</sup>M.</span></li><li id="cite_note-70"> <span id="mw-reference-text-cite_note-70" class="mw-reference-text">~ 2 x 10<sup>−3</sup>M.</span></li><li id="cite_note-71"> <span id="mw-reference-text-cite_note-71" class="mw-reference-text">~ 3 × 10<sup>−4</sup>M.</span></li><li id="cite_note-73"> <span id="mw-reference-text-cite_note-73" class="mw-reference-text">Tail suspension and enforced swimming.</span></li><li id="cite_note-75"> <span id="mw-reference-text-cite_note-75" class="mw-reference-text">Ostensibly correlated to anti-depressant activity.</span></li><li id="cite_note-76"> <span id="mw-reference-text-cite_note-76" class="mw-reference-text">An adrenergic antagonist selective for α<sub>1</sub> receptors.</span></li><li id="cite_note-77"> <span id="mw-reference-text-cite_note-77" class="mw-reference-text">Reversal of reserpine-induced hypothermia by a drug is a classical test for potential anti-depressant properties.</span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text">A selective inhibitor of the norepinephrine transporter.</span></li><li id="cite_note-80"> <span id="mw-reference-text-cite_note-80" class="mw-reference-text">Referred to here as "oxedrine".</span></li><li id="cite_note-85"> <span id="mw-reference-text-cite_note-85" class="mw-reference-text">A drug often used as a selective 5-HT<sub>2A</sub> antagonist.</span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text">Used as a non-selective β-antagonist</span></li><li id="cite_note-103"> <span id="mw-reference-text-cite_note-103" class="mw-reference-text">Referred to as "Sympathol".</span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Halostachine</li>
<li>Octopamine</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite id="CITEREFSA" class="citation web cs1">SA, HCI Solutions. <a href="javascript:if(confirm('https://compendium.ch/mpro/mnr/22158/html/fr?Platform=Desktop  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://compendium.ch/mpro/mnr/22158/html/fr?Platform=Desktop'" tppabs="https://compendium.ch/mpro/mnr/22158/html/fr?Platform=Desktop" class="external text external">"Neo-Synephrine HCl - compendium.ch"</a>. <i>compendium.ch</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2016-03-06</span></span>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFWagner_H.,_Ulrich-Merzenich_G.2009" class="citation journal cs1">Wagner H., Ulrich-Merzenich G. (2009). "Synergy research: approaching a new generation of phytopharmaceuticals". <i>Phytomedicine</i>. <b>16</b> (2–3): 97–110. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.phymed.2008.12.018  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.phymed.2008.12.018'" tppabs="https://doi.org/10.1016%2Fj.phymed.2008.12.018" class="external text external">10.1016/j.phymed.2008.12.018</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19211237  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19211237'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19211237" class="external text external">19211237</a>.</cite></span></li><li id="cite_note-Stew-4"> <span id="mw-reference-text-cite_note-Stew-4" class="mw-reference-text"><cite id="CITEREFStewart_I.,_Newhall_W._F.,_Edwards_G._J.1964" class="citation journal cs1">Stewart I., Newhall W. F., Edwards G. J. (1964). "The isolation and identification of synephrine in the leaves and fruit of Citrus". <i>J. Biol. Chem</i>. <b>239</b>: 930–932.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Stew2-5"> <span id="mw-reference-text-cite_note-Stew2-5" class="mw-reference-text"><a href="javascript:if(confirm('http://www.fshs.org/Proceedings/Password%20Protected/1963%20Vol.%2076/242-245%20%28STEWART%29.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.fshs.org/Proceedings/Password%20Protected/1963%20Vol.%2076/242-245%20%28STEWART%29.pdf'" tppabs="http://www.fshs.org/Proceedings/Password%20Protected/1963%20Vol.%2076/242-245%20%28STEWART%29.pdf" class="external autonumber external"></a> </span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFWheaton_T._A.,_Stewart_I.1970" class="citation journal cs1">Wheaton T. A., Stewart I. (1970). "The distribution of tyramine, N-methyltyramine, hordenine, octopamine and synephrine in higher plants". <i>Lloydia</i>. <b>33</b> (2): 244–254. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/5495514  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/5495514'" tppabs="https://pubmed.ncbi.nlm.nih.gov/5495514" class="external text external">5495514</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFKo_H._C.,_Chen_K._T.,_Chen_C._F.,_Su_J._P.,_Chen_C._M.,_Wang_G._J.2006" class="citation journal cs1">Ko H. C., Chen K. T., Chen C. F., Su J. P., Chen C. M., Wang G. J. (2006). "Chemical and biological comparisons on <i>Evodia</i> with two related species of different locations and conditions". <i>Journal of Ethnopharmacology</i>. <b>108</b> (2): 257–263. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jep.2006.05.020  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jep.2006.05.020'" tppabs="https://doi.org/10.1016%2Fj.jep.2006.05.020" class="external text external">10.1016/j.jep.2006.05.020</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16824714  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16824714'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16824714" class="external text external">16824714</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFSwinehart_J._A.,_Stermitz_F._R.1980" class="citation journal cs1">Swinehart J. A., Stermitz F. R. (1980). "Bishordeninyl terpene alkaloids and other constituents of <i>Zanthoxylum culantrillo</i> and <i>Z. coriaceum</i>". <i>Phytochemistry</i>. <b>19</b> (6): 1219–1223. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0031-9422%2880%2983087-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0031-9422%2880%2983087-1'" tppabs="https://doi.org/10.1016%2F0031-9422%2880%2983087-1" class="external text external">10.1016/0031-9422(80)83087-1</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFKim_S._P.,_Moon_E.,_Nam_S._H.,_Friedman_M.2012" class="citation journal cs1">Kim S. P., Moon E., Nam S. H., Friedman M. (2012). "Composition of Herba Pogostemonis water extract and protection of infected mice against <i>Salmonella typhimurium</i>-induced liver damage and mortality by stimulation of innate immune cells". <i>Journal of Agricultural and Food Chemistry</i>. <b>60</b> (49): 12122–12130. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjf304466t  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjf304466t'" tppabs="https://doi.org/10.1021%2Fjf304466t" class="external text external">10.1021/jf304466t</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23186318  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23186318'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23186318" class="external text external">23186318</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFShulginShulgin1997" class="citation book cs1">Shulgin, Alexander; Shulgin, Ann (1997). <i>Tihkal: The Continuation</i>. Berkeley: Transform Press. p.<span>&nbsp;</span>671. ISBN<span>&nbsp;</span><bdi>0-9630096-9-9</bdi>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFKusu_F.,_Li_X.-D.,_Takamura_K.1992" class="citation journal cs1">Kusu F., Li X.-D., Takamura K. (1992). <a href="javascript:if(confirm('https://doi.org/10.1248/cpb.40.3284  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1248/cpb.40.3284'" tppabs="https://doi.org/10.1248/cpb.40.3284" class="external text external">"Determination of synephrine and N-methyltyramine in Zhishi and Zhike (immature Citrus fruits) by high-performance liquid chromatography with electrochemical detection"</a>. <i>Chemical &amp; Pharmaceutical Bulletin</i>. <b>40</b> (12): 3284–3286. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1248%2Fcpb.40.3284  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1248%2Fcpb.40.3284'" tppabs="https://doi.org/10.1248%2Fcpb.40.3284" class="external text external">10.1248/cpb.40.3284</a></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Pellat-12"> <span id="mw-reference-text-cite_note-Pellat-12" class="mw-reference-text"><cite id="CITEREFPellati_F.,_Benvenuti_S.,_Melegari_M.2005" class="citation journal cs1">Pellati F., Benvenuti S., Melegari M. (2005). "Enantioselective LC analysis of synephrine in natural products on a protein-based chiral stationary phase". <i>Journal of Pharmaceutical and Biomedical Analysis</i>. <b>37</b> (5): 839–849. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jpba.2004.09.008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jpba.2004.09.008'" tppabs="https://doi.org/10.1016%2Fj.jpba.2004.09.008" class="external text external">10.1016/j.jpba.2004.09.008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15862657  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15862657'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15862657" class="external text external">15862657</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Mat-13"> <span id="mw-reference-text-cite_note-Mat-13" class="mw-reference-text"><cite id="CITEREFMattoli_L.,_Cangi_F.,_Maidecchi_A.,_Ghiara_C.,_Tubaro_M.,_Traldi_P.2005" class="citation journal cs1">Mattoli L., Cangi F., Maidecchi A., Ghiara C., Tubaro M., Traldi P. (2005). "A rapid liquid chromatography electrospray ionization mass spectrometry method for evaluation of synephrine in <i>Citrus aurantium</i> L. samples". <i>Journal of Agricultural and Food Chemistry</i>. <b>53</b> (26): 9860–9866. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjf051270%2B  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjf051270%2B'" tppabs="https://doi.org/10.1021%2Fjf051270%2B" class="external text external">10.1021/jf051270+</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16366666  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16366666'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16366666" class="external text external">16366666</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Av-16"> <span id="mw-reference-text-cite_note-Av-16" class="mw-reference-text"><cite id="CITEREFAvula_B.,_Upparapalli_S._K.,_Khan_I._A.2007" class="citation journal cs1">Avula B., Upparapalli S. K., Khan I. A. (2007). <a href="javascript:if(confirm('https://doi.org/10.1093/jaoac/90.3.633  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jaoac/90.3.633'" tppabs="https://doi.org/10.1093/jaoac/90.3.633" class="external text external">"Simultaneous analysis of adrenergic amines and flavonoids in citrus peel jams and fruit juices by liquid chromatography: part 2"</a>. <i>Journal of AOAC International</i>. <b>90</b> (3): 633–40. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjaoac%2F90.3.633  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjaoac%2F90.3.633'" tppabs="https://doi.org/10.1093%2Fjaoac%2F90.3.633" class="external text external">10.1093/jaoac/90.3.633</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17580614  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17580614'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17580614" class="external text external">17580614</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-XRef-17"> <span id="mw-reference-text-cite_note-XRef-17" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.plantnames.unimelb.edu.au/Sorting/Citrus.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.plantnames.unimelb.edu.au/Sorting/Citrus.html'" tppabs="http://www.plantnames.unimelb.edu.au/Sorting/Citrus.html" class="external text external">"Cross-reference for <i>Citrus</i> species and common names"</a>. Plantnames.unimelb.edu.au<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-12-10</span></span>.</cite></span></li><li id="cite_note-Kusu-18"> <span id="mw-reference-text-cite_note-Kusu-18" class="mw-reference-text"><cite id="CITEREFKusu_F.,_Matsumoto_K.,_Arai_K.,_Takamura_K.1996" class="citation journal cs1">Kusu F., Matsumoto K., Arai K., Takamura K. (1996). "Determination of synephrine enantiomers in food and conjugated synephrine in urine by high-performance liquid chromatography with electrochemical detection". <i>Analytical Biochemistry</i>. <b>235</b> (2): 191–194. doi:<a href="javascript:if(confirm('https://doi.org/10.1006%2Fabio.1996.0111  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1006%2Fabio.1996.0111'" tppabs="https://doi.org/10.1006%2Fabio.1996.0111" class="external text external">10.1006/abio.1996.0111</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8833327  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8833327'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8833327" class="external text external">8833327</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Blum-19"> <span id="mw-reference-text-cite_note-Blum-19" class="mw-reference-text"><a href="javascript:if(confirm('http://abc.herbalgram.org/site/DocServer/Bitter_Orange_Peel_and_Synephrine.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://abc.herbalgram.org/site/DocServer/Bitter_Orange_Peel_and_Synephrine.pdf'" tppabs="http://abc.herbalgram.org/site/DocServer/Bitter_Orange_Peel_and_Synephrine.pdf" class="external free external">http://abc.herbalgram.org/site/DocServer/Bitter_Orange_Peel_and_Synephrine.pdf</a></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFDragull_K.,_Breksa_A._P.,_Cain_B.2008" class="citation journal cs1">Dragull K., Breksa A. P., Cain B. (2008). "Synephrine content of juice from Satsuma Mandarins (<i>Citrus unshiu</i> Marcovitch.)". <i>Journal of Agricultural and Food Chemistry</i>. <b>56</b> (19): 8874–8878. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjf801225n  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjf801225n'" tppabs="https://doi.org/10.1021%2Fjf801225n" class="external text external">10.1021/jf801225n</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18771270  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18771270'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18771270" class="external text external">18771270</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFVieira_S._M.,_Theodoro_K._H.,_Glória_M._B._A.2007" class="citation journal cs1">Vieira S. M., Theodoro K. H., Glória M. B. A. (2007). "Profile and levels of bioactive amines in orange juice and orange soft drink". <i>Food Chemistry</i>. <b>100</b> (3): 895–903. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.foodchem.2005.10.050  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.foodchem.2005.10.050'" tppabs="https://doi.org/10.1016%2Fj.foodchem.2005.10.050" class="external text external">10.1016/j.foodchem.2005.10.050</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFUckoo_R._M.,_Jayaprakasha_G._K.,_Nelson_S._D.,_Patil_B._S.2011" class="citation journal cs1">Uckoo R. M., Jayaprakasha G. K., Nelson S. D., Patil B. S. (2011). "Rapid simultaneous determination of amines and organic acids in citrus using high-performance liquid chromatography". <i>Talanta</i>. <b>83</b> (3): 948–54. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.talanta.2010.10.063  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.talanta.2010.10.063'" tppabs="https://doi.org/10.1016%2Fj.talanta.2010.10.063" class="external text external">10.1016/j.talanta.2010.10.063</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21147342  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21147342'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21147342" class="external text external">21147342</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Ib-24"> <span id="mw-reference-text-cite_note-Ib-24" class="mw-reference-text"><cite id="CITEREFIbrahim_K._E.,_Couch_M._W.,_Williams_C._M.,_Budd_M._B.,_Yost_R._A.,_Midgley_J._M.1984" class="citation journal cs1">Ibrahim K. E., Couch M. W., Williams C. M., Budd M. B., Yost R. A., Midgley J. M. (1984). "Quantitative measurement of octopamines and synephrines in urine using capillary column gas chromatography negative ion chemical ionization mass spectrometry". <i>Analytical Chemistry</i>. <b>56</b> (9): 1695–1699. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fac00273a037  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fac00273a037'" tppabs="https://doi.org/10.1021%2Fac00273a037" class="external text external">10.1021/ac00273a037</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6435479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6435479'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6435479" class="external text external">6435479</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFWang_R.,_Wan_L.,_Li_Q.,_Liu_X.,_Huang_Y.2007" class="citation journal cs1">Wang R., Wan L., Li Q., Liu X., Huang Y. (2007). "Chemiluminescence of synephrine based on the cerium(IV)–rhodamine B system". <i>Luminescence</i>. <b>22</b> (2): 140–146. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fbio.937  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fbio.937'" tppabs="https://doi.org/10.1002%2Fbio.937" class="external text external">10.1002/bio.937</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17089346  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17089346'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17089346" class="external text external">17089346</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFWatson_D.G.,_Midgley_J.M.,_Chen_R.N.,_Huang_W.,_Bain_G.M.,_McDonald_N.M.,_Reid_J.L.,_McGhee_C.N.J.1990" class="citation journal cs1">Watson D.G., Midgley J.M., Chen R.N., Huang W., Bain G.M., McDonald N.M., Reid J.L., McGhee C.N.J. (1990). "Analysis of biogenic amines and their metabolites in biological tissues and fluids by gas chromatography—negative ion chemical ionization mass spectrometry (GC-NICIMS)". <i>Journal of Pharmaceutical and Biomedical Analysis</i>. <b>8</b> (8–12): 899–904. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0731-7085%2890%2980139-g  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0731-7085%2890%2980139-g'" tppabs="https://doi.org/10.1016%2F0731-7085%2890%2980139-g" class="external text external">10.1016/0731-7085(90)80139-g</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2100639  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2100639'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2100639" class="external text external">2100639</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFIbrahim_K._E.,_Couch_M._W.,_Williams_C._M.,_Fregly_M._J.,_Midgley_J._M.1985" class="citation journal cs1">Ibrahim K. E., Couch M. W., Williams C. M., Fregly M. J., Midgley J. M. (1985). "<i>m</i>-Octopamine: normal occurrence with <i>p</i>-octopamine in mammalian sympathetic nerves". <i>Journal of Neurochemistry</i>. <b>44</b> (6): 1862–1867. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1471-4159.1985.tb07180.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1471-4159.1985.tb07180.x'" tppabs="https://doi.org/10.1111%2Fj.1471-4159.1985.tb07180.x" class="external text external">10.1111/j.1471-4159.1985.tb07180.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3921667  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3921667'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3921667" class="external text external">3921667</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFD'Andrea_G.,_Granella_F.,_Leone_M.,_Perini_F.,_Farruggio_A.,_Bussone_G.2006" class="citation journal cs1">D'Andrea G., Granella F., Leone M., Perini F., Farruggio A., Bussone G. (2006). "Abnormal platelet trace amine profiles in migraine with and without aura". <i>Cephalalgia</i>. <b>26</b> (8): 968–972. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1468-2982.2006.01141.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1468-2982.2006.01141.x'" tppabs="https://doi.org/10.1111%2Fj.1468-2982.2006.01141.x" class="external text external">10.1111/j.1468-2982.2006.01141.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16886933  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16886933'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16886933" class="external text external">16886933</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Andrea-29"> <span id="mw-reference-text-cite_note-Andrea-29" class="mw-reference-text"><cite id="CITEREFD'Andrea_G.,_Terrazzino_S.,_Fortina_D.,_Farruggioa_A.,_Rinaldi_L.,_Leon_A.2003" class="citation journal cs1">D'Andrea G., Terrazzino S., Fortina D., Farruggioa A., Rinaldi L., Leon A. (2003). "HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes". <i>Neuroscience Letters</i>. <b>346</b> (1–2): 89–92. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0304-3940%2803%2900573-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0304-3940%2803%2900573-1'" tppabs="https://doi.org/10.1016%2Fs0304-3940%2803%2900573-1" class="external text external">10.1016/s0304-3940(03)00573-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12850555  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12850555'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12850555" class="external text external">12850555</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Pel-30"> <span id="mw-reference-text-cite_note-Pel-30" class="mw-reference-text"><cite id="CITEREFPellati_F.,_Benvenuti_S.,_Melegari_M.,_Firenzuoli_F.2002" class="citation journal cs1">Pellati F., Benvenuti S., Melegari M., Firenzuoli F. (2002). "Determination of adrenergic agonists from extracts and herbal products of <i>Citrus aurantium</i> L. var. amara by LC". <i>Journal of Pharmaceutical and Biomedical Analysis</i>. <b>29</b> (6): 1113–1119. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0731-7085%2802%2900153-x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0731-7085%2802%2900153-x'" tppabs="https://doi.org/10.1016%2Fs0731-7085%2802%2900153-x" class="external text external">10.1016/s0731-7085(02)00153-x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12110397  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12110397'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12110397" class="external text external">12110397</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFPellati_F.,_Cannazza_G.,_Benvenuti_S.2010" class="citation journal cs1">Pellati F., Cannazza G., Benvenuti S. (2010). "Study on the racemization of synephrine by off-column chiral high-performance liquid chromatography". <i>Journal of Chromatography A</i>. <b>1217</b> (21): 3503–3510. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.chroma.2010.03.026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.chroma.2010.03.026'" tppabs="https://doi.org/10.1016%2Fj.chroma.2010.03.026" class="external text external">10.1016/j.chroma.2010.03.026</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20399443  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20399443'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20399443" class="external text external">20399443</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFKusu_F.,_Matsumoto_K.,_Takamura_K.1995" class="citation journal cs1">Kusu F., Matsumoto K., Takamura K. (1995). <a href="javascript:if(confirm('https://www.jstage.jst.go.jp/article/cpb1958/43/7/43_7_1158/_pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstage.jst.go.jp/article/cpb1958/43/7/43_7_1158/_pdf'" tppabs="https://www.jstage.jst.go.jp/article/cpb1958/43/7/43_7_1158/_pdf" class="external text external">"Direct separation and determination of synephrine enantiomers by high-performance liquid chromatography with electrochemical detection"</a>. <i>Chemical &amp; Pharmaceutical Bulletin</i>. <b>43</b> (7): 1158–1161. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1248%2Fcpb.43.1158  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1248%2Fcpb.43.1158'" tppabs="https://doi.org/10.1248%2Fcpb.43.1158" class="external text external">10.1248/cpb.43.1158</a></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFRanieri_R._L.,_McLaughlin_J._L.1976" class="citation journal cs1">Ranieri R. L., McLaughlin J. L. (1976). "Cactus alkaloids. XXVIII. β-Phenethylamine and tetrahydroisoquinoline alkaloids from the Mexican cactus <i>Dolichothele longimamma</i>". <i>The Journal of Organic Chemistry</i>. <b>41</b> (2): 319–323. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjo00864a030  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjo00864a030'" tppabs="https://doi.org/10.1021%2Fjo00864a030" class="external text external">10.1021/jo00864a030</a>.</cite></span></li><li id="cite_note-Wheat-34"> <span id="mw-reference-text-cite_note-Wheat-34" class="mw-reference-text"><cite id="CITEREFWheaton_T._A.,_Stewart_I.1969" class="citation journal cs1">Wheaton T. A., Stewart I. (1969). "Biosynthesis of synephrine in citrus". <i>Phytochemistry</i>. <b>8</b>: 85–92. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0031-9422%2800%2985799-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0031-9422%2800%2985799-4'" tppabs="https://doi.org/10.1016%2Fs0031-9422%2800%2985799-4" class="external text external">10.1016/s0031-9422(00)85799-4</a>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite id="CITEREFBartley_A._P._Breksa_III,_Ishida_B._K.2010" class="citation journal cs1">Bartley A. P. Breksa III, Ishida B. K. (2010). "PCR amplification and cloning of tyrosine decarboxylase involved in synephrine biosynthesis in Citrus". <i>New Biotechnology</i>. <b>27</b> (4): 308–316. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.nbt.2010.04.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.nbt.2010.04.003'" tppabs="https://doi.org/10.1016%2Fj.nbt.2010.04.003" class="external text external">10.1016/j.nbt.2010.04.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20403465  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20403465'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20403465" class="external text external">20403465</a>.</cite></span></li><li id="cite_note-Trace_amine_template_1-36"> <span id="mw-reference-text-cite_note-Trace_amine_template_1-36" class="mw-reference-text"><cite id="CITEREFBroadley_KJ2010" class="citation journal cs1">Broadley KJ (March 2010). "The vascular effects of trace amines and amphetamines". <i>Pharmacology &amp; Therapeutics</i>. <b>125</b> (3): 363–375. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.pharmthera.2009.11.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.pharmthera.2009.11.005'" tppabs="https://doi.org/10.1016%2Fj.pharmthera.2009.11.005" class="external text external">10.1016/j.pharmthera.2009.11.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19948186  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19948186'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19948186" class="external text external">19948186</a>.</cite></span></li><li id="cite_note-Trace_amine_template_2-37"> <span id="mw-reference-text-cite_note-Trace_amine_template_2-37" class="mw-reference-text"><cite id="CITEREFLindemannHoener2005" class="citation journal cs1">Lindemann L, Hoener MC (May 2005). "A renaissance in trace amines inspired by a novel GPCR family". <i>Trends in Pharmacological Sciences</i>. <b>26</b> (5): 274–281. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.tips.2005.03.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.tips.2005.03.007'" tppabs="https://doi.org/10.1016%2Fj.tips.2005.03.007" class="external text external">10.1016/j.tips.2005.03.007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15860375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15860375'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15860375" class="external text external">15860375</a>.</cite></span></li><li id="cite_note-CYP2D6_tyramine-dopamine_metabolism-38"> <span id="mw-reference-text-cite_note-CYP2D6_tyramine-dopamine_metabolism-38" class="mw-reference-text"><cite id="CITEREFWangLiDongYue2014" class="citation journal cs1">Wang X, Li J, Dong G, Yue J (February 2014). "The endogenous substrates of brain CYP2D". <i>European Journal of Pharmacology</i>. <b>724</b>: 211–218. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejphar.2013.12.025  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejphar.2013.12.025'" tppabs="https://doi.org/10.1016%2Fj.ejphar.2013.12.025" class="external text external">10.1016/j.ejphar.2013.12.025</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24374199  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24374199'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24374199" class="external text external">24374199</a>.</cite></span></li><li id="cite_note-Sant-39"> <span id="mw-reference-text-cite_note-Sant-39" class="mw-reference-text"><cite id="CITEREFSantana_J.,_Sharpless_K._E.,_Nelson_B._C.2008" class="citation journal cs1">Santana J., Sharpless K. E., Nelson B. C. (2008). "Determination of para-synephrine and meta-synephrine positional isomers in bitter orange-containing dietary supplements by LC/UV and LC/MS/MS". <i>Food Chemistry</i>. <b>109</b> (3): 675–682. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.foodchem.2007.12.076  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.foodchem.2007.12.076'" tppabs="https://doi.org/10.1016%2Fj.foodchem.2007.12.076" class="external text external">10.1016/j.foodchem.2007.12.076</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite id="CITEREFHallerBenowitzJacob_p2005" class="citation journal cs1">Haller, C. A.; Benowitz, N. L.; Jacob p, 3rd (2005). "Hemodynamic effects of ephedra-free weight-loss supplements in humans". <i>The American Journal of Medicine</i>. <b>118</b> (9): 998–1003. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.amjmed.2005.02.034  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.amjmed.2005.02.034'" tppabs="https://doi.org/10.1016%2Fj.amjmed.2005.02.034" class="external text external">10.1016/j.amjmed.2005.02.034</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16164886  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16164886'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16164886" class="external text external">16164886</a>.</cite></span></li><li id="cite_note-Las-41"> <span id="mw-reference-text-cite_note-Las-41" class="mw-reference-text"><cite id="CITEREFLasch_F1927" class="citation journal cs1">Lasch F (1927). "Über die Pharmakologie des Sympathols, einer neuen adrenalinähnlichen Substanz. (Zugleich ein Beitrag zur Frage der chemischen Konstitution und pharmakodynamischen Wirkung)". <i>Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie</i>. <b>124</b> (3–4): 231–244. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf01861902  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf01861902'" tppabs="https://doi.org/10.1007%2Fbf01861902" class="external text external">10.1007/bf01861902</a>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite id="CITEREFHochrein_M.,_Keller_J.1930" class="citation journal cs1">Hochrein M., Keller J. (1930). "Über die Wirkung des Adrenalins und adrenalinverwandter Körper (Sympatol und Ephetonin) auf den Kreislauf". <i>Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie</i>. <b>156</b>: 37–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf01859312  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf01859312'" tppabs="https://doi.org/10.1007%2Fbf01859312" class="external text external">10.1007/bf01859312</a>.</cite></span></li><li id="cite_note-43"> <span id="mw-reference-text-cite_note-43" class="mw-reference-text">H. Legerlotz, US Patent 1,932,347 (October 24, 1933).</span></li><li id="cite_note-Stock-44"> <span id="mw-reference-text-cite_note-Stock-44" class="mw-reference-text"><cite id="CITEREFStockton_A._B.,_Pace_P._T.,_Tainter_M._L.1931" class="citation journal cs1">Stockton A. B., Pace P. T., Tainter M. L. (1931). "Some clinical actions and therapeutic uses of racemic synephrine". <i>Journal of Pharmacology and Experimental Therapeutics</i>. <b>41</b>: 11–20.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Tain-45"> <span id="mw-reference-text-cite_note-Tain-45" class="mw-reference-text"><cite id="CITEREFTainter_M._L.,_Seidenfeld_M._A.1930" class="citation journal cs1">Tainter M. L., Seidenfeld M. A. (1930). "Comparative actions of sympathomimetic compounds: synephrine-isomers and -ketone". <i>J. Pharmacol. Exp. Ther</i>. <b>40</b>: 23–42.</cite></span></li><li id="cite_note-46"> <span id="mw-reference-text-cite_note-46" class="mw-reference-text"><cite class="citation journal cs1">"Council on Pharmacy and Chemistry". <i>The Journal of the American Medical Association</i>. <b>94</b> (18): 1404. 1930. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.1930.02710440042013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.1930.02710440042013'" tppabs="https://doi.org/10.1001%2Fjama.1930.02710440042013" class="external text external">10.1001/jama.1930.02710440042013</a>.</cite></span></li><li id="cite_note-Hart-47"> <span id="mw-reference-text-cite_note-Hart-47" class="mw-reference-text"><cite id="CITEREFHartung_W1931" class="citation journal cs1">Hartung W (1931). "Epinephrine and related compounds: influence of structure on physiological activity". <i>Chemical Reviews</i>. <b>9</b> (3): 389–468. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fcr60034a002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fcr60034a002'" tppabs="https://doi.org/10.1021%2Fcr60034a002" class="external text external">10.1021/cr60034a002</a>.</cite></span></li><li id="cite_note-48"> <span id="mw-reference-text-cite_note-48" class="mw-reference-text"><cite id="CITEREFEditorial1944" class="citation journal cs1">Editorial (1944). "Sympatol-Stearns - A triumph of medical misinformation for physicians". <i>Journal of the American Medical Association</i>. <b>124</b> (14): 988. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.1944.02850140034013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.1944.02850140034013'" tppabs="https://doi.org/10.1001%2Fjama.1944.02850140034013" class="external text external">10.1001/jama.1944.02850140034013</a>.</cite></span></li><li id="cite_note-49"> <span id="mw-reference-text-cite_note-49" class="mw-reference-text">J. R. DiPalma (Ed.) (1965),<i>Drill's Pharmacology in Medicine,3rd Ed.</i>, p.494, McGraw-Hill, New York.</span></li><li id="cite_note-Wil-50"> <span id="mw-reference-text-cite_note-Wil-50" class="mw-reference-text">C. O. Wilson, O. Gisvold, and R. F. Doerge (Eds.) (1966). <i>Textbook of Organic Medicinal and Pharmaceutical Chemistry, 5th ed.,</i> p.438, Lippincott, Philadelphia.</span></li><li id="cite_note-51"> <span id="mw-reference-text-cite_note-51" class="mw-reference-text">D. M. Aviado (Ed.), 1972. <i>Krantz &amp; Carr's Pharmacologic Principles of Medical Practice, 8th Ed.</i>, p.526, Williams &amp; Wilkins, Baltimore.</span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text">R. C. Baselt (2008). <i>Disposition of Toxic Drugs and Chemicals in Man (8th Ed..)</i> pp. 1471–2, Biomedical Publications, Foster City, California. ISBN<span>&nbsp;</span>978-0-9626523-7-0.</span></li><li id="cite_note-53"> <span id="mw-reference-text-cite_note-53" class="mw-reference-text"><a href="javascript:if(confirm('http://www.mims.com/USA/drug/info/oxedrine/?type=full&mtype=generic  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.mims.com/USA/drug/info/oxedrine/?type=full&mtype=generic'" tppabs="http://www.mims.com/USA/drug/info/oxedrine/?type=full&mtype=generic" class="external free external">http://www.mims.com/USA/drug/info/oxedrine/?type=full&amp;mtype=generic</a></span></li><li id="cite_note-G._Rossato,_V._M_2011-54"> <span id="mw-reference-text-cite_note-G._Rossato,_V._M_2011-54" class="mw-reference-text"><cite id="CITEREFRossato_L._G.,_Costa_V._M.,_Limberger_R._P.,_de_Lourdes_Bastos_M.,_Remião_F.2011" class="citation journal cs1">Rossato L. G., Costa V. M., Limberger R. P., de Lourdes Bastos M., Remião F. (2011). "Synephrine: From trace concentrations to massive consumption in weight-loss". <i>Food and Chemical Toxicology</i>. <b>49</b> (1): 8–16. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.fct.2010.11.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.fct.2010.11.007'" tppabs="https://doi.org/10.1016%2Fj.fct.2010.11.007" class="external text external">10.1016/j.fct.2010.11.007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21075161  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21075161'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21075161" class="external text external">21075161</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-55"> <span id="mw-reference-text-cite_note-55" class="mw-reference-text"><cite id="CITEREFPenzak_S._R.,_Jann_M._W.,_Cold_J._A.,_Hon_Y._Y.,_Desai_H._D.,_Gurley_B._J.2001" class="citation journal cs1">Penzak S. R., Jann M. W., Cold J. A., Hon Y. Y., Desai H. D., Gurley B. J. (2001). "Seville (sour) orange juice: Synephrine content and cardiovascular effects in normotensive adults". <i>The Journal of Clinical Pharmacology</i>. <b>41</b> (10): 1059–1063. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F00912700122012652  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F00912700122012652'" tppabs="https://doi.org/10.1177%2F00912700122012652" class="external text external">10.1177/00912700122012652</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11583473  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11583473'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11583473" class="external text external">11583473</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-57"> <span id="mw-reference-text-cite_note-57" class="mw-reference-text"><cite id="CITEREFKappe_T.,_Armstrong_M._D.1965" class="citation journal cs1">Kappe T., Armstrong M. D. (1965). "Ultraviolet absorption spectra and apparent acidic dissociation constants of some phenolic amines". <i>Journal of Medicinal Chemistry</i>. <b>8</b> (3): 368–374. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjm00327a018  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjm00327a018'" tppabs="https://doi.org/10.1021%2Fjm00327a018" class="external text external">10.1021/jm00327a018</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14323148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14323148'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14323148" class="external text external">14323148</a>.</cite></span></li><li id="cite_note-58"> <span id="mw-reference-text-cite_note-58" class="mw-reference-text"><cite id="CITEREFBergmann_E._D.,_Sulzbacher_M.1951" class="citation journal cs1">Bergmann E. D., Sulzbacher M. (1951). "A new synthesis of 1-(<i>m</i>- and <i>p</i>-hydroxyphenyl)-2-methylaminoethanol (<i>m</i>- and <i>p</i>-sympathol)". <i>The Journal of Organic Chemistry</i>. <b>16</b>: 84–89. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjo01141a013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjo01141a013'" tppabs="https://doi.org/10.1021%2Fjo01141a013" class="external text external">10.1021/jo01141a013</a>.</cite></span></li><li id="cite_note-59"> <span id="mw-reference-text-cite_note-59" class="mw-reference-text">The Merck Index, 10th Ed. (1983), p. 1295, Merck &amp; Co., Rahway, NJ.</span></li><li id="cite_note-Midg-60"> <span id="mw-reference-text-cite_note-Midg-60" class="mw-reference-text">J. M. Midgley, C. M. Thonoor, A. F. Drake, C. M. Williams, A. E. Koziol and G. J. Palenik (1989). "The resolution and absolute configuration by X-ray crystallography of the isomeric octopamines and synephrines." <i>J. Chem. Soc., Perkin Trans. 2</i> 963-969.</span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite id="CITEREFPriestley_H._M.,_Moness_E.1940" class="citation journal cs1">Priestley H. M., Moness E. (1940). "A study of the intermediates in the preparation of sympathol". <i>J. Org. Chem</i>. <b>40</b>: 355–361.</cite></span></li><li id="cite_note-62"> <span id="mw-reference-text-cite_note-62" class="mw-reference-text"><cite class="citation journal cs1">Bergmann E. D., Sulzbacher M. (1951). "A new synthesi of 1-(<i>m</i>- and <i>p</i>-hydroxyphenyl)-2-methylaminoethanol (<i>m</i>- and <i>p</i>-sympathol)". <i>The Journal of Organic Chemistry</i>. <b>16</b>: 84–89. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjo01141a013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjo01141a013'" tppabs="https://doi.org/10.1021%2Fjo01141a013" class="external text external">10.1021/jo01141a013</a>.</cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><cite id="CITEREFLands_A._M.,_Rickards_E._E.,_Nash_V._L.,_Hooper_K._Z.1947" class="citation journal cs1">Lands A. M., Rickards E. E., Nash V. L., Hooper K. Z. (1947). "The pharmacology of vasodepressor compounds structurally related to the sympathomimetic amines". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>89</b> (4): 297–305. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20295509  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20295509'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20295509" class="external text external">20295509</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-64"> <span id="mw-reference-text-cite_note-64" class="mw-reference-text"><cite id="CITEREFUnna_K1951" class="citation journal cs1">Unna K (1951). "Pharmakologische Untersuchungen über neue Sympatolabkömmlinge". <i>Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie</i>. <b>213</b>: 207–234. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02432757  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02432757'" tppabs="https://doi.org/10.1007%2Fbf02432757" class="external text external">10.1007/bf02432757</a>.</cite></span></li><li id="cite_note-65"> <span id="mw-reference-text-cite_note-65" class="mw-reference-text"><cite id="CITEREFMcCulloch_J,_Deshmukh_VD,_Harper_AM1978" class="citation journal cs1">McCulloch J, Deshmukh VD, Harper AM (1978). "Indirect sympathomimetic agents and cerebral blood flow and metabolism". <i>European Journal of Pharmacology</i>. <b>47</b> (1): 11–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0014-2999%2878%2990368-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0014-2999%2878%2990368-0'" tppabs="https://doi.org/10.1016%2F0014-2999%2878%2990368-0" class="external text external">10.1016/0014-2999(78)90368-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/412682  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/412682'" tppabs="https://pubmed.ncbi.nlm.nih.gov/412682" class="external text external">412682</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-66"> <span id="mw-reference-text-cite_note-66" class="mw-reference-text"><cite id="CITEREFEhrismann_O.,_Maloff_G.1928" class="citation journal cs1">Ehrismann O., Maloff G. (1928). "Über zwei Gifte der Adrenalingruppe (<i>p</i>-Oxyphenyläthanolmethylamin und sein Keton". <i>Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie</i>. <b>136</b> (3–4): 172–184. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf01862149  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf01862149'" tppabs="https://doi.org/10.1007%2Fbf01862149" class="external text external">10.1007/bf01862149</a>.</cite></span></li><li id="cite_note-67"> <span id="mw-reference-text-cite_note-67" class="mw-reference-text">G. Kuschinsky (1930)). "Untersuchungen über Sympatol, einen adrenalinähnlichen Körper." <i>Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie</i> <b>156</b> 290 - 308.</span></li><li id="cite_note-Lands-68"> <span id="mw-reference-text-cite_note-Lands-68" class="mw-reference-text"><cite id="CITEREFLands_A._M.,_Grant_J._I.1952" class="citation journal cs1">Lands A. M., Grant J. I. (1952). "The vasopressor action and toxicity of cyclohexylethylamine derivatives". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>106</b> (3): 341–345. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13000630  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13000630'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13000630" class="external text external">13000630</a>.</cite></span></li><li id="cite_note-72"> <span id="mw-reference-text-cite_note-72" class="mw-reference-text"><cite id="CITEREFPapp_L._Szekeres1968" class="citation journal cs1">Papp L. Szekeres (1968). "The arrhythmogenic action of sympathomimetic amines". <i>European Journal of Pharmacology</i>. <b>3</b>: 4–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0014-2999%2868%2990042-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0014-2999%2868%2990042-3'" tppabs="https://doi.org/10.1016%2F0014-2999%2868%2990042-3" class="external text external">10.1016/0014-2999(68)90042-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4968334  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4968334'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4968334" class="external text external">4968334</a>.</cite></span></li><li id="cite_note-74"> <span id="mw-reference-text-cite_note-74" class="mw-reference-text"><cite id="CITEREFSong_D.-K.,_Suh_H.-W.,_Jung_J.-S.,_Wie_M.-B.,_Son_K.-H.,_Kim_Y.-H.1996" class="citation journal cs1">Song D.-K., Suh H.-W., Jung J.-S., Wie M.-B., Son K.-H., Kim Y.-H. (1996). "Antidepressant-like effects of <i>p</i>-synephrine in mouse models of immobility tests". <i>Neuroscience Letters</i>. <b>214</b> (2–3): 107–110. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0304-3940%2896%2912895-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0304-3940%2896%2912895-0'" tppabs="https://doi.org/10.1016%2F0304-3940%2896%2912895-0" class="external text external">10.1016/0304-3940(96)12895-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8878095  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8878095'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8878095" class="external text external">8878095</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-79"> <span id="mw-reference-text-cite_note-79" class="mw-reference-text"><cite id="CITEREFKim_K.-W.,_Kim_H.-D.,_Jung_J.-S.,_Woo_R.-S.,_Kim_H.-S.,_Suh_H.-W.,_Kim_Y.-H.,_Song_D.-K.2001" class="citation journal cs1">Kim K.-W., Kim H.-D., Jung J.-S., Woo R.-S., Kim H.-S., Suh H.-W., Kim Y.-H., Song D.-K. (2001). "Characterization of antidepressant-like effects of <i>p</i>-synephrine stereoisomers". <i>Naunyn-Schmiedeberg's Archives of Pharmacology</i>. <b>364</b>: 21–26. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs002100100416  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs002100100416'" tppabs="https://doi.org/10.1007%2Fs002100100416" class="external text external">10.1007/s002100100416</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11485034  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11485034'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11485034" class="external text external">11485034</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-81"> <span id="mw-reference-text-cite_note-81" class="mw-reference-text"><cite id="CITEREFBurgen_A._S._V.,_Iversen_L._L.1964" class="citation journal cs1">Burgen A. S. V., Iversen L. L. (1964). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510671  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510671'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510671" class="external text external">"The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart"</a>. <i>British Journal of Pharmacology and Chemotherapy</i>. <b>25</b> (1): 34–49. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1476-5381.1965.tb01754.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1476-5381.1965.tb01754.x'" tppabs="https://doi.org/10.1111%2Fj.1476-5381.1965.tb01754.x" class="external text external">10.1111/j.1476-5381.1965.tb01754.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510671  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510671'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510671" class="external text external">1510671</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19108208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19108208'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19108208" class="external text external">19108208</a>.</cite></span></li><li id="cite_note-82"> <span id="mw-reference-text-cite_note-82" class="mw-reference-text"><cite id="CITEREFWikberg_J._E._S.1978" class="citation journal cs1">Wikberg J. E. S. (1978). "Pharmacological classification of adrenergic α receptors in the guinea pig". <i>Nature</i>. <b>273</b> (5658): 164–166. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2F273164a0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2F273164a0'" tppabs="https://doi.org/10.1038%2F273164a0" class="external text external">10.1038/273164a0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25390  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25390'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25390" class="external text external">25390</a>.</cite></span></li><li id="cite_note-Brown-83"> <span id="mw-reference-text-cite_note-Brown-83" class="mw-reference-text"><cite id="CITEREFBrown_C.M.,_McGrath_J.C.,_Midgley_J.M.,_Muir_A.G.B.,_O'Brien_J.W.,_Thonoor_C.M.,_Williams_C.M.,_Wilson_V.G.1988" class="citation journal cs1">Brown C.M., McGrath J.C., Midgley J.M., Muir A.G.B., O'Brien J.W., Thonoor C.M., Williams C.M., Wilson V.G. (1988). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853804  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853804'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853804" class="external text external">"Activities of octopamine and synephrine stereoisomers on α-adrenoceptors"</a>. <i>British Journal of Pharmacology</i>. <b>93</b> (2): 417–429. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1476-5381.1988.tb11449.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1476-5381.1988.tb11449.x'" tppabs="https://doi.org/10.1111%2Fj.1476-5381.1988.tb11449.x" class="external text external">10.1111/j.1476-5381.1988.tb11449.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853804  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853804'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853804" class="external text external">1853804</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2833972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2833972'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2833972" class="external text external">2833972</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-84"> <span id="mw-reference-text-cite_note-84" class="mw-reference-text"><cite id="CITEREFRuffolo_R._R.,_Waddell_J._E.1983" class="citation journal cs1">Ruffolo R. R., Waddell J. E. (1983). "Aromatic and benzylic hydroxyl substitution of imidazolines and phenethylamines: differences in activity at alpha-1 and alpha-2 adrenergic receptors". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>224</b> (3): 559–566. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6131121  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6131121'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6131121" class="external text external">6131121</a>.</cite></span></li><li id="cite_note-86"> <span id="mw-reference-text-cite_note-86" class="mw-reference-text"><cite id="CITEREFHibino_T.,_Yuzurihara_M.,_Kase_Y.,_Takeda_A.2009" class="citation journal cs1">Hibino T., Yuzurihara M., Kase Y., Takeda A. (2009). <a href="javascript:if(confirm('https://www.jstage.jst.go.jp/article/jphs/111/1/111_09077FP/_pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstage.jst.go.jp/article/jphs/111/1/111_09077FP/_pdf'" tppabs="https://www.jstage.jst.go.jp/article/jphs/111/1/111_09077FP/_pdf" class="external text external">"Synephrine, a component of Evodiae Fructus, constricts isolated rat aorta via adrenergic and serotonergic receptors"</a>. <i>Journal of Pharmacological Sciences</i>. <b>111</b> (1): 73–81. doi:<a href="javascript:if(confirm('https://doi.org/10.1254%2Fjphs.09077fp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1254%2Fjphs.09077fp'" tppabs="https://doi.org/10.1254%2Fjphs.09077fp" class="external text external">10.1254/jphs.09077fp</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19721332  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19721332'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19721332" class="external text external">19721332</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-87"> <span id="mw-reference-text-cite_note-87" class="mw-reference-text"><cite id="CITEREFJordan_R.,_Midgley_J._M.,_Thonoor_C._M.,_Williams_C._M.1987" class="citation journal cs1">Jordan R., Midgley J. M., Thonoor C. M., Williams C. M. (1987). "Beta-adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig isolated atria and trachea". <i>J. Pharm. Pharmacol</i>. <b>39</b>: 752–754. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.2042-7158.1987.tb06986.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.2042-7158.1987.tb06986.x'" tppabs="https://doi.org/10.1111%2Fj.2042-7158.1987.tb06986.x" class="external text external">10.1111/j.2042-7158.1987.tb06986.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2890747  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2890747'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2890747" class="external text external">2890747</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text"><cite id="CITEREFCarpéné_C.,_Galitzky_J.,_Fontana_E.,_Atgié_C.,_Lafontan_M.,_Berlan_M.1999" class="citation journal cs1">Carpéné C., Galitzky J., Fontana E., Atgié C., Lafontan M., Berlan M. (1999). "Selective activation of β3-adrenoceptors by octopamine: comparative studies in mammalian fat cells". <i>Naunyn-Schmiedeberg's Archives of Pharmacology</i>. <b>359</b> (4): 310–321. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fpl00005357  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fpl00005357'" tppabs="https://doi.org/10.1007%2Fpl00005357" class="external text external">10.1007/pl00005357</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10344530  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10344530'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10344530" class="external text external">10344530</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-90"> <span id="mw-reference-text-cite_note-90" class="mw-reference-text"><cite id="CITEREFMa_G.,_Bavadeka_S._A.,_Schaneberg_B._T.,_Khan_I._A.,_Feller_D._R.2010" class="citation journal cs1">Ma G., Bavadeka S. A., Schaneberg B. T., Khan I. A., Feller D. R. (2010). "Effects of synephrine and beta-phenylephrine on human alpha-adrenoreceptor subtypes". <i>Planta Medica</i>. <b>76</b> (10): 981–986. doi:<a href="javascript:if(confirm('https://doi.org/10.1055%2Fs-0029-1240884  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1055%2Fs-0029-1240884'" tppabs="https://doi.org/10.1055%2Fs-0029-1240884" class="external text external">10.1055/s-0029-1240884</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20217639  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20217639'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20217639" class="external text external">20217639</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-pmid15860375-91"> <span id="mw-reference-text-cite_note-pmid15860375-91" class="mw-reference-text"><cite class="citation journal cs1">Lindemann, Lothar; Hoener, Marius C. (2005). "A renaissance in trace amines inspired by a novel GPCR family". <i>Trends in Pharmacological Sciences</i>. <b>26</b> (5): 274–81. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.tips.2005.03.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.tips.2005.03.007'" tppabs="https://doi.org/10.1016%2Fj.tips.2005.03.007" class="external text external">10.1016/j.tips.2005.03.007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15860375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15860375'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15860375" class="external text external">15860375</a>.</cite></span></li><li id="cite_note-92"> <span id="mw-reference-text-cite_note-92" class="mw-reference-text"><cite id="CITEREFWainscott_D._B.,_Little_S._P.,_Yin_T.,_Tu_Y.,_Rocco_V._P.,_He_J._X.,_Nelson_D._L.2007" class="citation journal cs1">Wainscott D. B., Little S. P., Yin T., Tu Y., Rocco V. P., He J. X., Nelson D. L. (2007). "Pharmacologic characterization of the cloned human Trace Amine-Associated Receptor1 (TAAR1) and evidence for species differences with the rat TAAR1". <i>Journal of Pharmacology and Experimental Therapeutics</i>. <b>320</b> (1): 475–485. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fjpet.106.112532  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fjpet.106.112532'" tppabs="https://doi.org/10.1124%2Fjpet.106.112532" class="external text external">10.1124/jpet.106.112532</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17038507  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17038507'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17038507" class="external text external">17038507</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-93"> <span id="mw-reference-text-cite_note-93" class="mw-reference-text"><cite id="CITEREFHengstmann_J._H.,_Aulepp_H.1978" class="citation journal cs1">Hengstmann J. H., Aulepp H. (1978). "Pharmacokinetics and metabolism of <sup>3</sup>H-synephphrine". <i>Arzneimittelforschung</i>. <b>28</b>: 2326–2331.</cite></span></li><li id="cite_note-94"> <span id="mw-reference-text-cite_note-94" class="mw-reference-text"><cite id="CITEREFSuzuki_O.,_Matsumoto_T.,_Oya_M.,_Katsumata_Y.1979" class="citation journal cs1">Suzuki O., Matsumoto T., Oya M., Katsumata Y. (1979). "Oxidation of synephrine by type A and type B monoamine oxidase". <i>Experientia</i>. <b>35</b> (10): 1283–1284. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf01963957  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf01963957'" tppabs="https://doi.org/10.1007%2Fbf01963957" class="external text external">10.1007/bf01963957</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/499398  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/499398'" tppabs="https://pubmed.ncbi.nlm.nih.gov/499398" class="external text external">499398</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-95"> <span id="mw-reference-text-cite_note-95" class="mw-reference-text">U. von Euler and G. Liljestrand (1929). <i>Skand. Arch. Physiol.</i> <b>55</b> 1.</span></li><li id="cite_note-96"> <span id="mw-reference-text-cite_note-96" class="mw-reference-text"><cite id="CITEREFPohle_F.,_Sarre_H.1940" class="citation journal cs1">Pohle F., Sarre H. (1940). "Der Wirkungsmechanismus eines neuen peripheren Kreislaufmittels im Vergleich mit Veritol und Sympatol beim Menschen". <i>Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie</i>. <b>196</b> (2–5): 408–430. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf01861124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf01861124'" tppabs="https://doi.org/10.1007%2Fbf01861124" class="external text external">10.1007/bf01861124</a>.</cite></span></li><li id="cite_note-97"> <span id="mw-reference-text-cite_note-97" class="mw-reference-text"><cite id="CITEREFHeim_F1948" class="citation journal cs1">Heim F (1948). "Über die Blutdruckwirksamkeit von Sympatol an Menschen nach Vorbehandlung mit Ephedrin, Veritol und Pervitin". <i>Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie</i>. <b>205</b>: 470–479. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf00246173  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf00246173'" tppabs="https://doi.org/10.1007%2Fbf00246173" class="external text external">10.1007/bf00246173</a>.</cite></span></li><li id="cite_note-98"> <span id="mw-reference-text-cite_note-98" class="mw-reference-text"><cite id="CITEREFNathanson_M._H.,_Miller_H.1950" class="citation journal cs1">Nathanson M. H., Miller H. (1950). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1520549  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1520549'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1520549" class="external text external">"The effect of new drugs on the rhythmic function of the heart"</a>. <i>Calif. Med</i>. <b>72</b> (4): 215–221. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1520549  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1520549'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1520549" class="external text external">1520549</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18731684  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18731684'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18731684" class="external text external">18731684</a>.</cite></span></li><li id="cite_note-Hoff-99"> <span id="mw-reference-text-cite_note-Hoff-99" class="mw-reference-text"><cite id="CITEREFHofstetterKreudervon_Bernuth1985" class="citation journal cs1">Hofstetter, R.; Kreuder, J.; von Bernuth, G. (1985). "The effect of oxedrine on the left ventricle and peripheral vascular resistance". <i>Arzneimittel-Forschung</i>. <b>35</b> (12): 1844–6. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4096743  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4096743'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4096743" class="external text external">4096743</a>.</cite></span></li><li id="cite_note-100"> <span id="mw-reference-text-cite_note-100" class="mw-reference-text"><cite id="CITEREFTiefensee_K1932" class="citation journal cs1">Tiefensee K (1932). "Therapy of bronchial asthma with adrenalin and the adrenalin derivatives ephedrine and sympatol". <i>Journal of Allergy</i>. <b>4</b>: 81. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0021-8707%2832%2990053-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0021-8707%2832%2990053-7'" tppabs="https://doi.org/10.1016%2Fs0021-8707%2832%2990053-7" class="external text external">10.1016/s0021-8707(32)90053-7</a>.</cite></span></li><li id="cite_note-101"> <span id="mw-reference-text-cite_note-101" class="mw-reference-text"><cite id="CITEREFFugh-BermanMyers2004" class="citation journal cs1">Fugh-Berman, Adriane; Myers, Adam (2004). "Citrus aurantium, an Ingredient of Dietary Supplements Marketed for Weight Loss: Current Status of Clinical and Basic Research". <i>Experimental Biology and Medicine</i>. <b>229</b> (8): 698–704. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F153537020422900802  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F153537020422900802'" tppabs="https://doi.org/10.1177%2F153537020422900802" class="external text external">10.1177/153537020422900802</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15337824  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15337824'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15337824" class="external text external">15337824</a>.</cite></span></li><li id="cite_note-Stohs-102"> <span id="mw-reference-text-cite_note-Stohs-102" class="mw-reference-text"><cite id="CITEREFStohs_S._J.,_Preuss_H._G.,_Shara_M.2011" class="citation journal cs1">Stohs S. J., Preuss H. G., Shara M. (2011). "The Safety of <i>Citrus aurantium</i> (Bitter Orange) and its primary protoalkaloid <i>p</i>-synephrine". <i>Phytotherapy Research</i>. <b>25</b> (10): 1421–1428. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fptr.3490  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fptr.3490'" tppabs="https://doi.org/10.1002%2Fptr.3490" class="external text external">10.1002/ptr.3490</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21480414  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21480414'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21480414" class="external text external">21480414</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-104"> <span id="mw-reference-text-cite_note-104" class="mw-reference-text"><cite id="CITEREFArbo_M._D.,_Schmitt_G._C.,_Limberger_M._F.,_Charão_M._F.,_Moro_Â._M.,_Ribeiro_G._L.,_Dallegrave_E.,_Garcia_S._C.,_Leal_M._B.,_Limberger_R._P.2009" class="citation journal cs1">Arbo M. D., Schmitt G. C., Limberger M. F., Charão M. F., Moro Â. M., Ribeiro G. L., Dallegrave E., Garcia S. C., Leal M. B., Limberger R. P. (2009). "Subchronic toxicity of <i>Citrus aurantium</i> L. (Rutaceae) extract and <i>p</i>-synephrine in mice". <i>Regulatory Toxicology and Pharmacology</i>. <b>54</b> (2): 114–117. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.yrtph.2009.03.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.yrtph.2009.03.001'" tppabs="https://doi.org/10.1016%2Fj.yrtph.2009.03.001" class="external text external">10.1016/j.yrtph.2009.03.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19275924  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19275924'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19275924" class="external text external">19275924</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-105"> <span id="mw-reference-text-cite_note-105" class="mw-reference-text"><cite id="CITEREFNasir_J._M.,_Durning_S._J.,_Ferguson_M.,_Barold_H._S.,_Haigney_M._C.2004" class="citation journal cs1">Nasir J. M., Durning S. J., Ferguson M., Barold H. S., Haigney M. C. (2004). <a href="javascript:if(confirm('https://doi.org/10.4065/79.8.1059  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065/79.8.1059'" tppabs="https://doi.org/10.4065/79.8.1059" class="external text external">"Exercise-induced syncope associated with QT prolongation and Ephedra-free Xenadrine"</a>. <i>Mayo Clinic Proceedings</i>. <b>79</b> (8): 1059–1062. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.4065%2F79.8.1059  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065%2F79.8.1059'" tppabs="https://doi.org/10.4065%2F79.8.1059" class="external text external">10.4065/79.8.1059</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15301335  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15301335'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15301335" class="external text external">15301335</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-106"> <span id="mw-reference-text-cite_note-106" class="mw-reference-text"><cite id="CITEREFBouchard_N.,_Hoffman_R._S.2004" class="citation journal cs1">Bouchard N., Hoffman R. S. (2004). <a href="javascript:if(confirm('https://doi.org/10.4065/79.12.1589-b  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065/79.12.1589-b'" tppabs="https://doi.org/10.4065/79.12.1589-b" class="external text external">"Synephrine is not Neo-Synephrine"</a>. <i>Mayo Clinic Proceedings</i>. <b>79</b> (12): 1589–1590. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.4065%2F79.12.1589-b  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065%2F79.12.1589-b'" tppabs="https://doi.org/10.4065%2F79.12.1589-b" class="external text external">10.4065/79.12.1589-b</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15595351  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15595351'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15595351" class="external text external">15595351</a>.</cite></span></li><li id="cite_note-107"> <span id="mw-reference-text-cite_note-107" class="mw-reference-text"><cite id="CITEREFBent_S.,_Padula_A.,_Neuhaus_J.2004" class="citation journal cs1">Bent S., Padula A., Neuhaus J. (2004). "Safety and efficacy of <i>Citrus aurantium</i> for weight loss". <i>The American Journal of Cardiology</i>. <b>94</b> (10): 1359–1361. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.amjcard.2004.07.137  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.amjcard.2004.07.137'" tppabs="https://doi.org/10.1016%2Fj.amjcard.2004.07.137" class="external text external">10.1016/j.amjcard.2004.07.137</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15541270  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15541270'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15541270" class="external text external">15541270</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-108"> <span id="mw-reference-text-cite_note-108" class="mw-reference-text"><cite id="CITEREFBouchard_N._C.,_Howland_M._A.,_Greller_H._A.,_Hoffman_R._S.,_Nelson_L._S.2005" class="citation journal cs1">Bouchard N. C., Howland M. A., Greller H. A., Hoffman R. S., Nelson L. S. (2005). <a href="javascript:if(confirm('https://doi.org/10.4065/80.4.541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065/80.4.541'" tppabs="https://doi.org/10.4065/80.4.541" class="external text external">"Ischemic stroke associated with use of an Ephedra-free dietary supplement containing synephrine"</a>. <i>Mayo Clinic Proceedings</i>. <b>80</b> (4): 541–545. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.4065%2F80.4.541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065%2F80.4.541'" tppabs="https://doi.org/10.4065%2F80.4.541" class="external text external">10.4065/80.4.541</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15819293  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15819293'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15819293" class="external text external">15819293</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-109"> <span id="mw-reference-text-cite_note-109" class="mw-reference-text"><cite id="CITEREFFirenzuoli_F.,_Gori_L.,_Galapai_C.2005" class="citation journal cs1">Firenzuoli F., Gori L., Galapai C. (2005). "Adverse reaction to an adrenergic herbal extract (<i>Citrus aurantium</i>)". <i>Phytomedicine</i>. <b>12</b> (3): 247–248. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.phymed.2004.02.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.phymed.2004.02.005'" tppabs="https://doi.org/10.1016%2Fj.phymed.2004.02.005" class="external text external">10.1016/j.phymed.2004.02.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15830849  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15830849'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15830849" class="external text external">15830849</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-110"> <span id="mw-reference-text-cite_note-110" class="mw-reference-text"><cite id="CITEREFHaaz_S.,_Fontaine_K._R.,_Cutter_G.,_Limdi_N.,_Perumean-Chaney_S.,_Allison_D._B.2006" class="citation journal cs1">Haaz S., Fontaine K. R., Cutter G., Limdi N., Perumean-Chaney S., Allison D. B. (2006). "<i>Citrus aurantium</i> and synephrine alkaloids in the treatment of overweight and obesity: an update". <i>Obesity Reviews</i>. <b>7</b>: 79–88. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1467-789x.2006.00195.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1467-789x.2006.00195.x'" tppabs="https://doi.org/10.1111%2Fj.1467-789x.2006.00195.x" class="external text external">10.1111/j.1467-789x.2006.00195.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16436104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16436104'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16436104" class="external text external">16436104</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-111"> <span id="mw-reference-text-cite_note-111" class="mw-reference-text"><cite id="CITEREFThomas_J._E.,_Munir_J._A.,_McIntyre_P._Z.,_Ferguson_M._A.2009" class="citation journal cs1">Thomas J. E., Munir J. A., McIntyre P. Z., Ferguson M. A. (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801940  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801940'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801940" class="external text external">"STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature"</a>. <i>Texas Heart Institute Journal</i>. <b>36</b> (6): 586–90. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801940  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801940'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801940" class="external text external">2801940</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20069086  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20069086'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20069086" class="external text external">20069086</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-112"> <span id="mw-reference-text-cite_note-112" class="mw-reference-text"><cite id="CITEREFThomas_J._E.,_Munir_J._A.,_McIntyre_P._Z.,_Ferguson_M._A.2010" class="citation journal cs1">Thomas J. E., Munir J. A., McIntyre P. Z., Ferguson M. A. (2010). "Lack of evidence that <i>p</i>-synephrine is responsible for STEMI". <i>Texas Heart Institute Journal</i>. <b>37</b>: 383–384.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-113"> <span id="mw-reference-text-cite_note-113" class="mw-reference-text"><cite id="CITEREFStohs_S._J.2010" class="citation journal cs1">Stohs S. J. (2010). "Assessment of the adverse event reports associated with <i>Citrus aurantium</i> (bitter orange) from April 2004 to October 2009". <i>Journal of Functional Foods</i>. <b>2</b> (4): 235–239. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jff.2010.10.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jff.2010.10.003'" tppabs="https://doi.org/10.1016%2Fj.jff.2010.10.003" class="external text external">10.1016/j.jff.2010.10.003</a>.</cite></span></li><li id="cite_note-114"> <span id="mw-reference-text-cite_note-114" class="mw-reference-text"><cite id="CITEREFEvans_P._D.1981" class="citation journal cs1">Evans P. D. (1981). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1245480  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1245480'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1245480" class="external text external">"Multiple receptor types for octopamine in the locust"</a>. <i>The Journal of Physiology</i>. <b>318</b>: 99–122. doi:<a href="javascript:if(confirm('https://doi.org/10.1113%2Fjphysiol.1981.sp013853  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1113%2Fjphysiol.1981.sp013853'" tppabs="https://doi.org/10.1113%2Fjphysiol.1981.sp013853" class="external text external">10.1113/jphysiol.1981.sp013853</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1245480  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1245480'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1245480" class="external text external">1245480</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6275071  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6275071'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6275071" class="external text external">6275071</a>.</cite></span></li><li id="cite_note-115"> <span id="mw-reference-text-cite_note-115" class="mw-reference-text"><cite id="CITEREFCarlson_A._D.1968" class="citation journal cs1">Carlson A. D. (1968). "Effect of drugs on luminescence in larval fireflies". <i>The Journal of Experimental Biology</i>. <b>49</b> (1): 195–199. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4386272  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4386272'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4386272" class="external text external">4386272</a>.</cite></span></li><li id="cite_note-116"> <span id="mw-reference-text-cite_note-116" class="mw-reference-text"><cite id="CITEREFBattelle_A.,_Kravitz_E._A.1978" class="citation journal cs1">Battelle A., Kravitz E. A. (1978). "Targets of octopamine action in the lobster: cyclic nucleotide changes and physiological effects in hemolymph, heart and exoskeletal muscle". <i>J. Pharmacol. Exp. Ther</i>. <b>205</b>: 438–448. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/347053  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/347053'" tppabs="https://pubmed.ncbi.nlm.nih.gov/347053" class="external text external">347053</a>.</cite></span></li><li id="cite_note-117"> <span id="mw-reference-text-cite_note-117" class="mw-reference-text"><cite id="CITEREFBarrett_M.,_Orchard_I.1990" class="citation journal cs1">Barrett M., Orchard I. (1990). "Serotonin-induced elevation of cAMP levels in the epidermis of the blood-sucking bug, <i>Rhodnius prolixus</i>". <i>Journal of Insect Physiology</i>. <b>36</b> (9): 625–633. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0022-1910%2890%2990066-o  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0022-1910%2890%2990066-o'" tppabs="https://doi.org/10.1016%2F0022-1910%2890%2990066-o" class="external text external">10.1016/0022-1910(90)90066-o</a>.</cite></span></li><li id="cite_note-118"> <span id="mw-reference-text-cite_note-118" class="mw-reference-text"><cite id="CITEREFRachinsky_A1994" class="citation journal cs1">Rachinsky A (1994). "Octopamine and serotonin influence on <i>corpora allata</i> activity in honey bee (<i>Apis mellifera</i>) larvae". <i>Journal of Insect Physiology</i>. <b>40</b> (7): 549–554. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0022-1910%2894%2990141-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0022-1910%2894%2990141-4'" tppabs="https://doi.org/10.1016%2F0022-1910%2894%2990141-4" class="external text external">10.1016/0022-1910(94)90141-4</a>.</cite></span></li><li id="cite_note-119"> <span id="mw-reference-text-cite_note-119" class="mw-reference-text"><cite id="CITEREFWoodring_J.,_Hoffmann_K._H.1994" class="citation journal cs1">Woodring J., Hoffmann K. H. (1994). "The effects of octopamine, dopamine and serotonin on juvenile hormone synthesis, In vitro, in the cricket, <i>Gryllus bimaculatus</i>". <i>Journal of Insect Physiology</i>. <b>40</b> (9): 797–802. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0022-1910%2894%2990009-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0022-1910%2894%2990009-4'" tppabs="https://doi.org/10.1016%2F0022-1910%2894%2990009-4" class="external text external">10.1016/0022-1910(94)90009-4</a>.</cite></span></li></ol></div>

<div role="navigation" class="navbox" aria-labelledby="Neurotransmitters" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align: center;"><div id="Neurotransmitters" style="font-size:114%;margin:0 4em">Neurotransmitters</div></th></tr><tr><th scope="row" class="navbox-group" style="text-align: center;;width:1%">Amino acid-derived</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Major excitatory/inhibitory systems</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;font-weight:normal;">Glutamate system</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Agmatine.htm" tppabs="https://ptable.com/wiki/compounds/A/Agmatine" title="Agmatine">Agmatine</a></li>
<li><a href="Aspartic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspartic_acid" title="Aspartic acid">Aspartic acid (aspartate)</a></li>
<li>Glutamic acid (glutamate)</li>
<li><a href="Glutathione.htm" tppabs="https://ptable.com/wiki/compounds/A/Glutathione" title="Glutathione">Glutathione</a></li>
<li><a href="Glycine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycine" title="Glycine">Glycine</a></li>
<li><a href="S-Nitrosoglutathione.htm" tppabs="https://ptable.com/wiki/compounds/A/S-Nitrosoglutathione" title="S-Nitrosoglutathione">GSNO</a></li>
<li>GSSG</li>
<li><a href="Kynurenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Kynurenic_acid" title="Kynurenic acid">Kynurenic acid</a></li>
<li><a href="N-Acetylaspartic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylaspartic_acid" title="N-Acetylaspartic acid">NAA</a></li>
<li>NAAG</li>
<li><a href="Proline.htm" tppabs="https://ptable.com/wiki/compounds/A/Proline" title="Proline">Proline</a></li>
<li><a href="Serine.htm" tppabs="https://ptable.com/wiki/compounds/A/Serine" title="Serine">Serine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;font-weight:normal;">GABA system</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Gamma-Aminobutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Aminobutyric_acid" title="Gamma-Aminobutyric acid">GABA</a></li>
<li>GABOB</li>
<li><a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;font-weight:normal;">Glycine system</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Alanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alanine" title="Alanine">α-Alanine</a></li>
<li>β-Alanine</li>
<li><a href="Glycine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycine" title="Glycine">Glycine</a></li>
<li><a href="Hypotaurine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hypotaurine" title="Hypotaurine">Hypotaurine</a></li>
<li><a href="Proline.htm" tppabs="https://ptable.com/wiki/compounds/A/Proline" title="Proline">Proline</a></li>
<li><a href="Sarcosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sarcosine" title="Sarcosine">Sarcosine</a></li>
<li><a href="Serine.htm" tppabs="https://ptable.com/wiki/compounds/A/Serine" title="Serine">Serine</a></li>
<li><a href="Taurine.htm" tppabs="https://ptable.com/wiki/compounds/A/Taurine" title="Taurine">Taurine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;font-weight:normal;">GHB system</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a></li>
<li>T-HCA (GHC)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Biogenic amines</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;font-weight:normal; text-align: center;">Monoamines</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>6-OHM</li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Epinephrine (adrenaline)</li>
<li><a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin">NAS (normelatonin)</a></li>
<li>Norepinephrine (noradrenaline)</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;font-weight:normal; text-align: center;">Trace amines</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Iodothyronamine</li>
<li><a href="N-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methylphenethylamine" title="N-Methylphenethylamine">N-Methylphenethylamine</a></li>
<li><a href="N-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methyltryptamine" title="N-Methyltryptamine">N-Methyltryptamine</a></li>
<li><a href="Norfenefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Norfenefrine" title="Norfenefrine"><i>m</i>-Octopamine</a></li>
<li><i>p</i>-Octopamine</li>
<li>Phenylethanolamine</li>
<li><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li>
<li><a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">Tryptamine</a></li>
<li><i>m</i>-Tyramine</li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine"><i>p</i>-Tyramine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;font-weight:normal; text-align: center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Neuropeptides</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align: center;;width:1%">Lipid-derived</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Endocannabinoids" scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Endocannabinoids</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-AG</li>
<li>2-AGE (noladin ether)</li>
<li><span class="new">2-ALPI</span></li>
<li>2-OG</li>
<li>AA-5-HT</li>
<li><a href="Anandamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Anandamide" title="Anandamide">Anandamide (AEA)</a></li>
<li>DEA</li>
<li>LPI</li>
<li>NADA</li>
<li>NAGly</li>
<li>OEA</li>
<li><a href="Oleamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Oleamide" title="Oleamide">Oleamide</a></li>
<li>PEA</li>
<li>RVD-Hpα</li>
<li>SEA</li>
<li>Virodhamine (O-AEA)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Neurosteroids</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align: center;;width:1%">Nucleobase-derived</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Nucleosides" scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Nucleosides</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Adenosine_system" scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Adenosine system</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Adenosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Adenosine" title="Adenosine">Adenosine</a></li>
<li><a href="Adenosine_diphosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Adenosine_diphosphate" title="Adenosine diphosphate">ADP</a></li>
<li><a href="Adenosine_monophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Adenosine_monophosphate" title="Adenosine monophosphate">AMP</a></li>
<li><a href="Adenosine_triphosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Adenosine_triphosphate" title="Adenosine triphosphate">ATP</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align: center;;width:1%">Vitamin-derived</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Cholinergic_system" scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Cholinergic system</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">Acetylcholine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align: center;;width:1%">Miscellaneous</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Gasotransmitters" scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Gasotransmitters</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Carbon_monoxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbon_monoxide" title="Carbon monoxide">Carbon monoxide (CO)</a></li>
<li><a href="Hydrogen_sulfide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrogen_sulfide" title="Hydrogen sulfide">Hydrogen sulfide (H<sub>2</sub>S)</a></li>
<li><a href="Nitric_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitric_oxide" title="Nitric oxide">Nitric oxide (NO)</a></li></ul>
</div></td></tr></tbody></table><div>

    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Candidates" scope="row" class="navbox-group" style="width:1%;font-weight:normal; text-align: center;">Candidates</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Acetaldehyde.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetaldehyde" title="Acetaldehyde">Acetaldehyde</a></li>
<li><a href="Ammonia.htm" tppabs="https://ptable.com/wiki/compounds/A/Ammonia" title="Ammonia">Ammonia (NH<sub>3</sub>)</a></li>
<li><a href="Carbonyl_sulfide.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbonyl_sulfide" title="Carbonyl sulfide">Carbonyl sulfide (COS)</a></li>
<li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide (N<sub>2</sub>O)</a></li>
<li><a href="Sulfur_dioxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfur_dioxide" title="Sulfur dioxide">Sulfur dioxide (SO<sub>2</sub>)</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Adrenergic_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Adrenergic_receptor_modulators" style="font-size:114%;margin:0 4em">Adrenergic receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">α<sub>1</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 6-FNE</li>
<li>Amidephrine</li>
<li>Anisodine</li>
<li><a href="Buspirone.htm" tppabs="https://ptable.com/wiki/compounds/A/Buspirone" title="Buspirone">Buspirone</a></li>
<li>Cirazoline</li>
<li>Corbadrine</li>
<li><span class="new">Desglymidodrine</span></li>
<li><span class="new">Dexisometheptene</span></li>
<li><a href="Dipivefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipivefrine" title="Dipivefrine">Dipivefrine</a></li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Droxidopa (<small>L</small>-DOPS)</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li><a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine</a></li>
<li>Etilefrine</li>
<li>Etilevodopa</li>
<li>Ethylnorepinephrine</li>
<li>Indanidine</li>
<li>Isometheptene</li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine"><small>L</small>-Phenylalanine</a></li>
<li><a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine"><small>L</small>-Tyrosine</a></li>
<li>Melevodopa</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li><a href="Methoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxamine" title="Methoxamine">Methoxamine</a></li>
<li><a href="Methyldopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyldopa" title="Methyldopa">Methyldopa</a></li>
<li><a href="Midodrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Midodrine" title="Midodrine">Midodrine</a></li>
<li>Naphazoline</li>
<li>Norepinephrine</li>
<li>Octopamine</li>
<li><a href="Oxymetazoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymetazoline" title="Oxymetazoline">Oxymetazoline</a></li>
<li><a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">Phenylephrine</a></li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li>
<li>Tetryzoline</li>
<li>Tiamenidine</li>
<li><span class="new">XP21279</span></li>
<li>Xylometazoline</li></ul>

<ul><li><i>Antagonists:</i> Abanoquil</li>
<li>Adimolol</li>
<li>Ajmalicine</li>
<li><a href="Alfuzosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfuzosin" title="Alfuzosin">Alfuzosin</a></li>
<li>Amosulalol</li>
<li>Anisodamine</li>
<li>Arotinolol</li>
<li>Atiprosin</li>
<li>Atypical antipsychotics (e.g., brexpiprazole, <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>)</li>
<li>Benoxathian</li>
<li>Buflomedil</li>
<li>Bunazosin</li>
<li><a href="Carvedilol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carvedilol" title="Carvedilol">Carvedilol</a></li>
<li><a href="Corynanthine.htm" tppabs="https://ptable.com/wiki/compounds/A/Corynanthine" title="Corynanthine">Corynanthine</a></li>
<li><a href="Dapiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Dapiprazole" title="Dapiprazole">Dapiprazole</a></li>
<li>Domesticine</li>
<li><a href="Doxazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxazosin" title="Doxazosin">Doxazosin</a></li>
<li>Ergolines (e.g., <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">lisuride</a>, <a href="Terguride.htm" tppabs="https://ptable.com/wiki/compounds/A/Terguride" title="Terguride">terguride</a>)</li>
<li>Etoperidone</li>
<li>Eugenodilol</li>
<li>Fenspiride</li>
<li><a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li>Indoramin</li>
<li><a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">Ketanserin</a></li>
<li>L-765,314</li>
<li><a href="Labetalol.htm" tppabs="https://ptable.com/wiki/compounds/A/Labetalol" title="Labetalol">Labetalol</a></li>
<li><a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li>
<li>Mepiprazole</li>
<li>Metazosin</li>
<li>Monatepil</li>
<li>Moxisylyte</li>
<li><a href="Naftopidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Naftopidil" title="Naftopidil">Naftopidil</a></li>
<li>Nantenine</li>
<li>Neldazosin</li>
<li>Niaprazine</li>
<li><a href="Nicergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicergoline" title="Nicergoline">Nicergoline</a></li>
<li>Niguldipine</li>
<li>Pardoprunox</li>
<li>Pelanserin</li>
<li>Perlapine</li>
<li>Phendioxan</li>
<li><a href="Phenoxybenzamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenoxybenzamine" title="Phenoxybenzamine">Phenoxybenzamine</a></li>
<li><a href="Phentolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentolamine" title="Phentolamine">Phentolamine</a></li>
<li><a href="Phenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpiperazine" title="Phenylpiperazine">Phenylpiperazine</a> antidepressants (e.g., hydroxynefazodone, <a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">nefazodone</a>, <a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">trazodone</a>, triazoledione)</li>
<li>Piperoxan</li>
<li><a href="Prazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prazosin" title="Prazosin">Prazosin</a></li>
<li>Quinazosin</li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li>Ritanserin</li>
<li>Silodosin</li>
<li><a href="Spiperone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spiperone" title="Spiperone">Spiperone</a></li>
<li>Talipexole</li>
<li><a href="Tamsulosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamsulosin" title="Tamsulosin">Tamsulosin</a></li>
<li><a href="Terazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Terazosin" title="Terazosin">Terazosin</a></li>
<li>Tiodazosin</li>
<li><a href="Tolazoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolazoline" title="Tolazoline">Tolazoline</a></li>
<li>Tetracyclic antidepressants (e.g., <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">maprotiline</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a>)</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">clomipramine</a>, <a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">doxepin</a>, <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>, <a href="Trimipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimipramine" title="Trimipramine">trimipramine</a>)</li>
<li>Trimazosin</li>
<li>Typical antipsychotics (e.g., <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">fluphenazine</a>, <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">thioridazine</a>)</li>
<li>Urapidil</li>
<li>WB-4101</li>
<li>Zolertine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">α<sub>2</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> (R)-3-Nitrobiphenyline</li>
<li>4-NEMD</li>
<li>6-FNE</li>
<li><a href="Amitraz.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitraz" title="Amitraz">Amitraz</a></li>
<li><a href="Apraclonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Apraclonidine" title="Apraclonidine">Apraclonidine</a></li>
<li><a href="Brimonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brimonidine" title="Brimonidine">Brimonidine</a></li>
<li>Cannabivarin</li>
<li><a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">Clonidine</a></li>
<li>Corbadrine</li>
<li>Detomidine</li>
<li><a href="Dexmedetomidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexmedetomidine" title="Dexmedetomidine">Dexmedetomidine</a></li>
<li><a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">Dihydroergotamine</a></li>
<li><a href="Dipivefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipivefrine" title="Dipivefrine">Dipivefrine</a></li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Droxidopa (<small>L</small>-DOPS)</li>
<li>Etilevodopa</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li><a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">Ergotamine</a></li>
<li><a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine</a></li>
<li>Etilefrine</li>
<li>Ethylnorepinephrine</li>
<li><a href="Guanabenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanabenz" title="Guanabenz">Guanabenz</a></li>
<li><a href="Guanfacine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanfacine" title="Guanfacine">Guanfacine</a></li>
<li>Guanoxabenz</li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine"><small>L</small>-Phenylalanine</a></li>
<li><a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine"><small>L</small>-Tyrosine</a></li>
<li><a href="Lofexidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lofexidine" title="Lofexidine">Lofexidine</a></li>
<li>Medetomidine</li>
<li>Melevodopa</li>
<li><a href="Methyldopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyldopa" title="Methyldopa">Methyldopa</a></li>
<li>Mivazerol</li>
<li>Naphazoline</li>
<li>Norepinephrine</li>
<li><a href="Oxymetazoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymetazoline" title="Oxymetazoline">Oxymetazoline</a></li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li>Piperoxan</li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><span class="new">Rezatomidine</span></li>
<li><a href="Rilmenidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rilmenidine" title="Rilmenidine">Rilmenidine</a></li>
<li>Romifidine</li>
<li>Talipexole</li>
<li><span class="new">Tasipimidine</span></li>
<li>Tetrahydrozoline</li>
<li>Tiamenidine</li>
<li><a href="Tizanidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tizanidine" title="Tizanidine">Tizanidine</a></li>
<li>Tolonidine</li>
<li>Urapidil</li>
<li><span class="new">Vatinoxan</span></li>
<li><span class="new">XP21279</span></li>
<li><a href="Xylazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Xylazine" title="Xylazine">Xylazine</a></li>
<li>Xylometazoline</li></ul>

<ul><li><i>Antagonists:</i> <a href="Pyrimidinylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyrimidinylpiperazine" title="Pyrimidinylpiperazine">1-PP</a></li>
<li>Adimolol</li>
<li>Amesergide</li>
<li>Aptazapine</li>
<li>Atipamezole</li>
<li>Atypical antipsychotics (e.g., asenapine, brexpiprazole, <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, lurasidone, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="Paliperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Paliperidone" title="Paliperidone">paliperidone</a>, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, zotepine)</li>
<li>Azapirones (e.g., <a href="Buspirone.htm" tppabs="https://ptable.com/wiki/compounds/A/Buspirone" title="Buspirone">buspirone</a>, gepirone, ipsapirone, tandospirone)</li>
<li>BRL-44408</li>
<li>Buflomedil</li>
<li>Cirazoline</li>
<li>Efaroxan</li>
<li>Esmirtazapine</li>
<li>Fenmetozole</li>
<li>Fluparoxan</li>
<li>Idazoxan</li>
<li><a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li>NAN-190</li>
<li>Pardoprunox</li>
<li><a href="Phentolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentolamine" title="Phentolamine">Phentolamine</a></li>
<li><a href="Phenoxybenzamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenoxybenzamine" title="Phenoxybenzamine">Phenoxybenzamine</a></li>
<li>Piperoxan</li>
<li>Piribedil</li>
<li>Rauwolscine</li>
<li>Rotigotine</li>
<li>SB-269970</li>
<li>Setiptiline</li>
<li>Spiroxatrine</li>
<li>Sunepitron</li>
<li><a href="Tolazoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolazoline" title="Tolazoline">Tolazoline</a></li>
<li>Typical antipsychotics (e.g., <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">fluphenazine</a>, <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">thioridazine</a>)</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">β</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Abediterol</li>
<li>Alifedrine</li>
<li>Amibegron</li>
<li><a href="Arbutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arbutamine" title="Arbutamine">Arbutamine</a></li>
<li><a href="Arformoterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Arformoterol" title="Arformoterol">Arformoterol</a></li>
<li>Arotinolol</li>
<li>BAAM</li>
<li><a href="Bambuterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bambuterol" title="Bambuterol">Bambuterol</a></li>
<li>Befunolol</li>
<li><a href="Bitolterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bitolterol" title="Bitolterol">Bitolterol</a></li>
<li>Broxaterol</li>
<li>Buphenine</li>
<li>Carbuterol</li>
<li>Carmoterol</li>
<li>Cimaterol</li>
<li><a href="Clenbuterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clenbuterol" title="Clenbuterol">Clenbuterol</a></li>
<li>Colterol</li>
<li>Corbadrine</li>
<li>Denopamine</li>
<li><a href="Dipivefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipivefrine" title="Dipivefrine">Dipivefrine</a></li>
<li><a href="Dobutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dobutamine" title="Dobutamine">Dobutamine</a></li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Dopexamine</li>
<li>Droxidopa (<small>L</small>-DOPS)</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li><a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine</a></li>
<li>Etafedrine</li>
<li>Etilefrine</li>
<li>Etilevodopa</li>
<li>Ethylnorepinephrine</li>
<li><a href="Fenoterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenoterol" title="Fenoterol">Fenoterol</a></li>
<li><a href="Formoterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Formoterol" title="Formoterol">Formoterol</a></li>
<li>Hexoprenaline</li>
<li>Higenamine</li>
<li>Indacaterol</li>
<li><a href="Isoetarine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoetarine" title="Isoetarine">Isoetarine</a></li>
<li><a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="Isoxsuprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoxsuprine" title="Isoxsuprine">Isoxsuprine</a></li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine"><small>L</small>-Phenylalanine</a></li>
<li><a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine"><small>L</small>-Tyrosine</a></li>
<li>Levosalbutamol</li>
<li>Mabuterol</li>
<li>Melevodopa</li>
<li>Methoxyphenamine</li>
<li><a href="Methyldopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyldopa" title="Methyldopa">Methyldopa</a></li>
<li>Mirabegron</li>
<li>Norepinephrine</li>
<li><a href="Orciprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Orciprenaline" title="Orciprenaline">Orciprenaline</a></li>
<li>Oxyfedrine</li>
<li>PF-610355</li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><a href="Pirbuterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pirbuterol" title="Pirbuterol">Pirbuterol</a></li>
<li>Prenalterol</li>
<li>Ractopamine</li>
<li><a href="Procaterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Procaterol" title="Procaterol">Procaterol</a></li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li>Reproterol</li>
<li>Rimiterol</li>
<li><a href="Ritodrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritodrine" title="Ritodrine">Ritodrine</a></li>
<li><a href="Salbutamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salbutamol" title="Salbutamol">Salbutamol</a></li>
<li><a href="Salmeterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salmeterol" title="Salmeterol">Salmeterol</a></li>
<li>Solabegron</li>
<li><a href="Terbutaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Terbutaline" title="Terbutaline">Terbutaline</a></li>
<li>Tretoquinol</li>
<li>Tulobuterol</li>
<li>Vilanterol</li>
<li>Xamoterol</li>
<li><span class="new">XP21279</span></li>
<li>Zilpaterol</li>
<li>Zinterol</li></ul>

<ul><li><i>Antagonists:</i> <a href="Acebutolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Acebutolol" title="Acebutolol">Acebutolol</a></li>
<li>Adaprolol</li>
<li>Adimolol</li>
<li>Afurolol</li>
<li><a href="Alprenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Alprenolol" title="Alprenolol">Alprenolol</a></li>
<li>Alprenoxime</li>
<li>Amosulalol</li>
<li>Ancarolol</li>
<li>Arnolol</li>
<li>Arotinolol</li>
<li><a href="Atenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Atenolol" title="Atenolol">Atenolol</a></li>
<li>Befunolol</li>
<li><a href="Betaxolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Betaxolol" title="Betaxolol">Betaxolol</a></li>
<li><a href="Bevantolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bevantolol" title="Bevantolol">Bevantolol</a></li>
<li><a href="Bisoprolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisoprolol" title="Bisoprolol">Bisoprolol</a></li>
<li>Bopindolol</li>
<li>Bornaprolol</li>
<li>Brefonalol</li>
<li>Bucindolol</li>
<li>Bucumolol</li>
<li>Bufetolol</li>
<li>Bufuralol</li>
<li>Bunitrolol</li>
<li>Bunolol</li>
<li>Bupranolol</li>
<li>Butaxamine</li>
<li>Butidrine</li>
<li>Butofilolol</li>
<li>Capsinolol</li>
<li>Carazolol</li>
<li>Carpindolol</li>
<li><a href="Carteolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carteolol" title="Carteolol">Carteolol</a></li>
<li><a href="Carvedilol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carvedilol" title="Carvedilol">Carvedilol</a></li>
<li>Celiprolol</li>
<li>Cetamolol</li>
<li>Cicloprolol</li>
<li>Cinamolol</li>
<li>Cloranolol</li>
<li>Cyanopindolol</li>
<li>Dalbraminol</li>
<li>Dexpropranolol</li>
<li>Diacetolol</li>
<li>Dichloroisoprenaline</li>
<li>Dihydroalprenolol</li>
<li>Dilevalol</li>
<li>Diprafenone</li>
<li>Draquinolol</li>
<li>Ecastolol</li>
<li>Epanolol</li>
<li>Ericolol</li>
<li>Ersentilide</li>
<li>Esatenolol</li>
<li>Esprolol</li>
<li>Eugenodilol</li>
<li>Exaprolol</li>
<li>Falintolol</li>
<li>Flestolol</li>
<li>Flusoxolol</li>
<li>Hydroxycarteolol</li>
<li>Hydroxytertatolol</li>
<li>ICI-118,551</li>
<li>Idropranolol</li>
<li>Indenolol</li>
<li>Indopanolol</li>
<li>Iodocyanopindolol</li>
<li>Iprocrolol</li>
<li>Isoxaprolol</li>
<li>Isamoltane</li>
<li><a href="Labetalol.htm" tppabs="https://ptable.com/wiki/compounds/A/Labetalol" title="Labetalol">Labetalol</a></li>
<li>Landiolol</li>
<li>Levobetaxolol</li>
<li><a href="Levobunolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levobunolol" title="Levobunolol">Levobunolol</a></li>
<li>Levomoprolol</li>
<li>Medroxalol</li>
<li>Mepindolol</li>
<li><a href="Metipranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metipranolol" title="Metipranolol">Metipranolol</a></li>
<li><a href="Metoprolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoprolol" title="Metoprolol">Metoprolol</a></li>
<li>Moprolol</li>
<li><a href="Nadolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Nadolol" title="Nadolol">Nadolol</a></li>
<li>Nadoxolol</li>
<li>Nebivolol</li>
<li>Nifenalol</li>
<li>Nipradilol</li>
<li><a href="Oxprenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxprenolol" title="Oxprenolol">Oxprenolol</a></li>
<li>Pacrinolol</li>
<li>Pafenolol</li>
<li>Pamatolol</li>
<li>Pargolol</li>
<li><a href="Penbutolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Penbutolol" title="Penbutolol">Penbutolol</a></li>
<li><a href="Pindolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pindolol" title="Pindolol">Pindolol</a></li>
<li><a href="Practolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Practolol" title="Practolol">Practolol</a></li>
<li>Primidolol</li>
<li>Procinolol</li>
<li>Pronethalol</li>
<li><a href="Propafenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Propafenone" title="Propafenone">Propafenone</a></li>
<li><a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">Propranolol</a></li>
<li>Ridazolol</li>
<li>Ronactolol</li>
<li>Soquinolol</li>
<li><a href="Sotalol.htm" tppabs="https://ptable.com/wiki/compounds/A/Sotalol" title="Sotalol">Sotalol</a></li>
<li>Spirendolol</li>
<li>SR 59230A</li>
<li>Sulfinalol</li>
<li>Talinolol</li>
<li>Tazolol</li>
<li>Tertatolol</li>
<li>Tienoxolol</li>
<li>Tilisolol</li>
<li><a href="Timolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Timolol" title="Timolol">Timolol</a></li>
<li>Tiprenolol</li>
<li>Tolamolol</li>
<li>Toliprolol</li>
<li>Xibenolol</li>
<li>Xipranolol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">See<br>also</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>List of adrenergic drugs</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Human_trace_amine-associated_receptor_ligands" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Human_trace_amine-associated_receptor_ligands" style="font-size:114%;margin:0 4em">Human trace amine-associated receptor ligands</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">TAAR1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;text-align: center">Endogenous<sup><span>†</span></sup></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;background:white"><div style="padding:0em 0.25em">
<ul><li>Classical monoamine neurotransmitters 
<ul><li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li>
<li>Norepinephrine</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a></li></ul></li>
<li>Trace amines
<ul><li>3-Iodothyronamine</li>
<li><a href="3-Methoxytyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a></li>
<li><a href="N-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methylphenethylamine" title="N-Methylphenethylamine"><i>N</i>-Methylphenethylamine</a></li>
<li><a href="N-Methyltyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methyltyramine" title="N-Methyltyramine"><i>N</i>-Methyltyramine</a></li>
<li><i>m</i>-Octopamine</li>
<li><i>p</i>-Octopamine</li>
<li><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li>Phenylethanolamine</li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li>
<li><a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">Tryptamine</a></li>
<li><i>m</i>-Tyramine</li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Tyramine" title="Para-Tyramine" class="mw-redirect"><i>p</i>-Tyramine</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;text-align: center">Synthetic<sup><span>‡</span></sup></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;background:white"><div style="padding:0em 0.25em">
<ul><li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li>DOB</li>
<li><a href="2,5-Dimethoxy-4-ethylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-ethylamphetamine" title="2,5-Dimethoxy-4-ethylamphetamine">DOET</a></li>
<li>4-Hydroxyamphetamine</li>
<li><a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>2-Methylphenethylamine</li>
<li>3-Methylphenethylamine</li>
<li>4-Methylphenethylamine</li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Methylphenethylamine</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>3-MMA</li>
<li>Norfenfluramine</li>
<li><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermine</a></li>
<li><i>o</i>-PIT</li>
<li>Propylhexedrine</li>
<li>RO5166017</li>
<li><i>N</i>,<i>N</i>-Dimethylphenethylamine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Neutral antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span>&nbsp;</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Inverse agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>EPPTB (RO5212773)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">TAAR2</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Agonists<sup><span>‡</span></sup></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"><span>&nbsp;</span></div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Neutral antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span>&nbsp;</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">TAAR5</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Agonists<sup><span>‡</span></sup></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>N</i>,<i>N</i>-Dimethylethylamine</li>
<li><a href="Trimethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethylamine" title="Trimethylamine">Trimethylamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Neutral antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span>&nbsp;</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Inverse agonists<sup><span>‡</span></sup></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Iodothyronamine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><div style="float: left;"><small><sup><span>†</span></sup> References for all endogenous human TAAR1 ligands are provided at List of trace amines</small></div>
<p><br></p>

<div style="float: left;"><small><sup><span>‡</span></sup> References for synthetic TAAR1 agonists can be found at TAAR1 or in the associated compound articles. For TAAR2 and TAAR5 agonists and inverse agonists, see TAAR for references.</small></div>

<p><br></p>
<small><i><b>See also:</b> Receptor/signaling modulators</i></small></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Phenethylamines" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Phenethylamines" style="font-size:114%;margin:0 4em">Phenethylamines</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenethylamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Psychedelics:</i> 25B-NBOMe</li>
<li>25C-NBOMe</li>
<li>25D-NBOMe</li>
<li>25I-NBOMe</li>
<li>25N-NBOMe</li></ul>

<ul><li><a href="2C-B.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-B" title="2C-B">2C-B</a></li>
<li><span class="new">2C-B-AN</span></li>
<li><span class="new">2C-Bn</span></li>
<li><span class="new">2C-Bu</span></li>
<li>2C-C</li>
<li><span class="new">2C-CN</span></li>
<li><span class="new">2C-CP</span></li>
<li>2C-D</li>
<li>2C-E</li>
<li><span class="new">2C-EF</span></li>
<li>2C-F</li>
<li>2C-G</li>
<li>2C-G-1</li>
<li>2C-G-2</li>
<li>2C-G-3</li>
<li>2C-G-4</li>
<li>2C-G-5</li>
<li>2C-G-6</li>
<li>2C-G-N</li>
<li><a href="2C-H.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-H" title="2C-H">2C-H</a></li>
<li>2C-I</li>
<li>2C-iP</li>
<li>2C-N</li>
<li><span class="new">2C-NH2</span></li>
<li>2C-O</li>
<li>2C-O-4</li>
<li>2C-P</li>
<li><span class="new">2C-Ph</span></li>
<li>2C-SE</li>
<li>2C-T</li>
<li>2C-T-2</li>
<li><span class="new">2C-T-3</span></li>
<li>2C-T-4</li>
<li><span class="new">2C-T-5</span></li>
<li><span class="new">2C-T-6</span></li>
<li>2C-T-7</li>
<li>2C-T-8</li>
<li>2C-T-9</li>
<li><span class="new">2C-T-10</span></li>
<li><span class="new">2C-T-11</span></li>
<li><span class="new">2C-T-12</span></li>
<li>2C-T-13</li>
<li><span class="new">2C-T-14</span></li>
<li>2C-T-15</li>
<li>2C-T-16</li>
<li>2C-T-17</li>
<li><span class="new">2C-T-18</span></li>
<li>2C-T-19</li>
<li><span class="new">2C-T-20</span></li>
<li>2C-T-21</li>
<li><span class="new">2C-T-22</span></li>
<li><span class="new">2C-T-22.5</span></li>
<li><span class="new">2C-T-23</span></li>
<li><span class="new">2C-T-24</span></li>
<li><span class="new">2C-T-25</span></li>
<li><span class="new">2C-T-27</span></li>
<li><span class="new">2C-T-28</span></li>
<li><span class="new">2C-T-30</span></li>
<li><span class="new">2C-T-31</span></li>
<li><span class="new">2C-T-32</span></li>
<li><span class="new">2C-T-33</span></li>
<li><span class="new">2C-TFE</span></li>
<li>2C-TFM</li>
<li>2C-YN</li>
<li><span class="new">2C-V</span></li></ul>

<ul><li>Allylescaline</li>
<li>DESOXY</li>
<li>Escaline</li>
<li>Isoproscaline</li>
<li>Jimscaline</li>
<li>Macromerine</li>
<li>MEPEA</li>
<li>Mescaline</li>
<li>Metaescaline</li>
<li>Methallylescaline</li>
<li>Proscaline</li>
<li>Psi-2C-T-4</li>
<li>TCB-2</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a><br><i>Stimulants:</i> Phenylethanolamine</li>
<li>Hordenine</li>
<li><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">α-Methylphenethylamine</a> (amphetamine)</li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Methylphenethylamine</a></li>
<li><i>m</i>-Methylphenethylamine</li>
<li><a href="N-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methylphenethylamine" title="N-Methylphenethylamine"><i>N</i>-Methylphenethylamine</a></li>
<li><i>o</i>-Methylphenethylamine</li>
<li><i>p</i>-Methylphenethylamine</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li></ul>

<ul><li><i>Entactogens:</i> Lophophine</li>
<li>MDPEA</li>
<li>MDMPEA<br><i>Others:</i> BOH</li>
<li><a href="3,4-Dimethoxyphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Dimethoxyphenethylamine" title="3,4-Dimethoxyphenethylamine">DMPEA</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Amphetamines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Psychedelics:</i> 3C-BZ</li>
<li>3C-E</li>
<li>3C-P</li>
<li>Aleph</li>
<li>Beatrice</li>
<li>Bromo-DragonFLY</li>
<li>D-Deprenyl</li>
<li><a href="Dimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoxyamphetamine" title="Dimethoxyamphetamine">DMA</a></li>
<li><span class="new">DMCPA</span></li>
<li>DMMDA</li>
<li>DOB</li>
<li>DOC</li>
<li>DOEF</li>
<li><a href="2,5-Dimethoxy-4-ethylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-ethylamphetamine" title="2,5-Dimethoxy-4-ethylamphetamine">DOET</a></li>
<li>DOI</li>
<li><a href="2,5-Dimethoxy-4-methylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a></li>
<li>DON</li>
<li>DOPR</li>
<li>DOTFM</li>
<li>Ganesha</li>
<li>MMDA</li>
<li>MMDA-2</li>
<li>Psi-DOM</li>
<li><a href="Trimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethoxyamphetamine" title="Trimethoxyamphetamine">TMA</a></li>
<li>TeMA<br><i>Stimulants:</i> 2-FA</li>
<li>2-FMA</li>
<li>3-FA</li>
<li>3-FMA</li>
<li>Acridorex</li>
<li>Alfetamine</li>
<li>Amfecloral</li>
<li>Amfepentorex</li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="Levoamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>)</li>
<li>Amphetaminil</li>
<li>Benfluorex</li>
<li><a href="Benzphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li><a href="Cathine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathine" title="Cathine">Cathine</a></li>
<li>Clobenzorex</li>
<li>Dimethylamphetamine</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li>Etilamfetamine</li>
<li>Fencamfamin</li>
<li>Fencamine</li>
<li><a href="Fenethylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">Fenfluramine</a> (<a href="Dexfenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexfenfluramine" title="Dexfenfluramine">Dexfenfluramine</a>, Levofenfluramine)</li>
<li><a href="Fenproporex.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li>Flucetorex</li>
<li>Fludorex</li>
<li>Formetorex</li>
<li>Furfenorex</li>
<li>Gepefrine</li>
<li>4-Hydroxyamphetamine</li>
<li>Iofetamine</li>
<li>Isopropylamphetamine</li>
<li>Lefetamine</li>
<li><a href="Lisdexamfetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a></li>
<li>Mefenorex</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a> (Dextromethamphetamine, Levomethamphetamine)</li>
<li>Methoxyphenamine</li>
<li>MMA</li>
<li>Morforex</li>
<li>Norfenfluramine</li>
<li><a href="L-Norpseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Norpseudoephedrine" title="L-Norpseudoephedrine"><span style="font-size:90%;">L </span>-Norpseudoephedrine</a></li>
<li>N,alpha-Diethylphenylethylamine</li>
<li>Oxifentorex</li>
<li>Oxilofrine</li>
<li>Ortetamine</li>
<li>PBA</li>
<li>PCA</li>
<li>Phenpromethamine</li>
<li>PFA</li>
<li>PFMA</li>
<li>PIA</li>
<li><a href="Para-Methoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Methoxyamphetamine" title="Para-Methoxyamphetamine">PMA</a></li>
<li>PMEA</li>
<li>PMMA</li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><a href="Pholedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Propylamphetamine</li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Tiflorex</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li>
<li>Xylopropamine</li>
<li>Zylofuramine<br><i>Entactogens:</i> 4-FA</li>
<li>4-FMA</li>
<li>4-MA</li>
<li>4-MMA</li>
<li>4-MTA</li>
<li>5-APB</li>
<li>5-APDB</li>
<li>5-EAPB</li>
<li>5-IT</li>
<li>5-MAPB</li>
<li>5-MAPDB</li>
<li>6-APB</li>
<li>6-APDB</li>
<li>6-Chloro-MDMA</li>
<li>6-EAPB</li>
<li>6-IT</li>
<li>6-MAPB</li>
<li>6-MAPDB</li>
<li>EDA</li>
<li>IAP</li>
<li>2,3-MDA</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">3,4-MDA (tenamfetamine)</a></li>
<li>MDEA</li>
<li>MDHMA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>MDOH</li>
<li>Methamnetamine</li>
<li>MMDMA</li>
<li>Naphthylaminopropane</li>
<li>TAP<br><i>Others:</i> 3,4-DCA</li>
<li>Amiflamine</li>
<li>DiFMDA</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a> (also <span style="font-size:90%;">D </span>-Deprenyl)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Stimulants:</i> <a href="Chlorphentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a></li>
<li>Cloforex</li>
<li><a href="Clortermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clortermine" title="Clortermine">Clortermine</a></li>
<li>Etolorex</li>
<li><a href="Mephentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephentermine" title="Mephentermine">Mephentermine</a></li>
<li>Pentorex</li>
<li><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermine</a><br><i>Entactogens:</i> MDPH</li>
<li>MDMPH<br><i>Others:</i> Cericlamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cathinones</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Stimulants:</i> 3-FMC</li>
<li>4-MC</li>
<li>4-BMC</li>
<li>4-CMC</li>
<li>4-EMC</li>
<li>4-FMC</li>
<li>4-MEC</li>
<li>4-MeMABP</li>
<li>4-MPD</li>
<li><a href="Amfepramone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li>Benzedrone</li>
<li>Brephedrone</li>
<li>Buphedrone</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a></li>
<li>Dimethylcathinone</li>
<li>Ethcathinone</li>
<li>Eutylone</li>
<li>Hydroxybupropion</li>
<li>Methcathinone</li>
<li>Methedrone</li>
<li>NEB</li>
<li>N-Ethylhexedrone</li>
<li>N-Ethylpentedrone</li>
<li>Pentedrone</li>
<li>Pentylone</li>
<li>Radafaxine<br><i>Entactogens:</i> 3,4-DMMC</li>
<li>3-MMC</li>
<li>Butylone</li>
<li>Ethylone</li>
<li>Methylone</li>
<li>Methylenedioxycathinone</li>
<li>Mephedrone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylisobutylamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Entactogens:</i> 4-CAB</li>
<li>4-MAB</li>
<li>Ariadne</li>
<li>BDB</li>
<li>Butylone</li>
<li>EBDB</li>
<li>Eutylone</li>
<li>MBDB<br><i>Stimulants:</i> Phenylisobutylamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylalkylpyrrolidines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Stimulants:</i> α-PBP</li>
<li>α-PHP</li>
<li>α-PPP</li>
<li>α-PVP</li>
<li>MDPBP</li>
<li>MDPPP</li>
<li>MDPV</li>
<li>4-MePBP</li>
<li>4-MePHP</li>
<li>4-MePPP</li>
<li>MOPPP</li>
<li>MOPVP</li>
<li>MPBP</li>
<li>MPHP</li>
<li>MPPP</li>
<li>Naphyrone</li>
<li>PEP</li>
<li>Prolintane</li>
<li>Pyrovalerone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Catecholamines<br><span style="font-size:90%;">(and close relatives) </span></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>6-FNE</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Oxidopamine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Oxidopamine'" tppabs="https://ptable.com/wiki/compounds/A/6-Hydroxydopamine" title="6-Hydroxydopamine" class="mw-redirect">6-OHDA</a></li>
<li><a href="Alpha-Methyldopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyldopamine" title="Alpha-Methyldopamine">a-Me-DA</a></li>
<li>a-Me-TRA</li>
<li>Adrenochrome</li>
<li>Ciladopa</li>
<li><span style="font-size:90%;">D </span>-DOPA (Dextrodopa)</li>
<li>Dimetofrine</li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Epinephrine</li>
<li>Epinine</li>
<li>Etilefrine</li>
<li>Ethylnorepinephrine</li>
<li><a href="Fenclonine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenclonine" title="Fenclonine">Fenclonine</a></li>
<li>Ibopamine</li>
<li><a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="Isoetarine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoetarine" title="Isoetarine">Isoetarine</a></li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><span style="font-size:90%;">L </span>-DOPA</a> (Levodopa)</li>
<li><a href="L-DOPS.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPS" title="L-DOPS" class="mw-redirect"><span style="font-size:90%;">L </span>-DOPS</a> (Droxidopa)</li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Phenylalanine" title="L-Phenylalanine" class="mw-redirect"><span style="font-size:90%;">L </span>-Phenylalanine</a></li>
<li><span style="font-size:90%;">L </span>-Tyrosine</li>
<li><i>m</i>-Tyramine</li>
<li>Metanephrine</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li>Metaterol</li>
<li><a href="Metirosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Metirosine" title="Metirosine">Metirosine</a></li>
<li><a href="Methyldopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyldopa" title="Methyldopa">Methyldopa</a></li>
<li>N,N-Dimethyldopamine</li>
<li>Nordefrin (Levonordefrin)</li>
<li>Norepinephrine</li>
<li><a href="Norfenefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Norfenefrine" title="Norfenefrine">Norfenefrine</a> (<i>m</i>-Octopamine)</li>
<li>Normetanephrine</li>
<li><a href="Orciprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Orciprenaline" title="Orciprenaline">Orciprenaline</a></li>
<li><i>p</i>-Octopamine</li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine"><i>p</i>-Tyramine</a></li>
<li><a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">Phenylephrine</a></li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Miscellaneous</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>AL-LAD</li>
<li>Amidephrine</li>
<li><a href="Arbutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arbutamine" title="Arbutamine">Arbutamine</a></li>
<li>Cafedrine</li>
<li>Denopamine</li>
<li>Desvenlafaxine</li>
<li>Diphenidine</li>
<li>Dizocilpine</li>
<li><a href="Dobutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dobutamine" title="Dobutamine">Dobutamine</a></li>
<li>Dopexamine</li>
<li>Ephenidine</li>
<li>Etafedrine</li>
<li>ETH-LAD</li>
<li>Famprofazone</li>
<li>Fluorolintane</li>
<li>Hexapradol</li>
<li>IP-LAD</li>
<li>Lysergic acid amide</li>
<li>Lysergic acid 2-butyl amide</li>
<li>Lysergic acid 2,4-dimethylazetidide</li>
<li><a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">Lysergic acid diethylamide</a></li>
<li><a href="Methoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxamine" title="Methoxamine">Methoxamine</a></li>
<li>Methoxphenidine</li>
<li>MT-45</li>
<li>PARGY-LAD</li>
<li>Phenibut</li>
<li>PRO-LAD</li>
<li>Pronethalol</li>
<li><a href="Salbutamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salbutamol" title="Salbutamol">Salbutamol</a> (Levosalbutamol)</li>
<li>Solriamfetol</li>
<li>Theodrenaline</li>
<li><a href="Thiamphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiamphenicol" title="Thiamphenicol">Thiamphenicol</a></li>
<li>UWA-101</li></ul>
</div></td></tr></tbody></table></div>








<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-06-22" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Synephrine&oldid=963944185  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Synephrine&oldid=963944185'" tppabs="https://en.wikipedia.org/wiki/?title=Synephrine&oldid=963944185">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>